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KEY ROLE OF THE POTENTIALLY RECRUITABLE LUNG ON THE MECHANICAL EF-
FECTS OF PEEP DURING ARDS
Caironi P1, Cressoni M1, Chiumello D1, Ranieri M V2, Quintel M3, Cornejo R4, Bugedo G4,
Gattinoni L1
1Ist. di Anestesia e Rianimazione, Ospedale Maggiore Policlinico, Milano, 2Dip. di Anestesia,
Ospedale S. Giovanni Battista-Molinette, Torino, Italy, 3Anaesthesiologie II, Universitatsklinikum,
Gottigen, Germany, 4Dep. de Anestesiologia y Medicina Intensiva, Pontificia Universidad Catolica,
Santiago, Chile
INTRODUCTION. In acute respiratory distress syndrome (ARDS), the effect of high level of positive
end-expiratory pressure (PEEP) on outcome likely depends on the balance between its beneficial and
detrimental effects (reduction of intra-tidal lung opening-closing [O/C] vs. increase of alveolar strain).
We hypothesized that these effects may extensively vary according to the amount of the potentially
recruitable lung (PRL) of each patient.
METHODS. Sixty-eight patients underwent a whole lung CT-scan at 5 and 15 cmH2O PEEP, and
at airway plateau pressure of 45 cmH2O. End-inspiratory non-aerated lung tissue was estimated from
the CT pressure-volume curve. Intra-tidal lung O/C was defined as the difference between the end-
expiratory and end-inspiratory non-aerated lung tissue at each PEEP step, while keeping tidal-volume
(VT) constant (8-10 ml/kg). Alveolar strain was calculated as the ratio between the end-inspiratory lung
inflation and end-expiratory lung volume. The amount of PRL was defined as the proportion of lung
tissue regaining aeration between 5 and 45 cmH2O airway pressures.
RESULTS. Patients were divided into those with a lower- and those with a higher-PRL, according to its
median value (9 percent). At 5 cmH2O PEEP, lung O/C in patients with a higher-PRL was greater than
that of patients with a lower-PRL (141±85 [SD] vs. 20±22 gr, P<0.01), which was almost negligible
(2±2% of the lung weight). In contrast, alveolar strain was identical in the two groups (0.38±0.17 vs.
0.41±0.15). Increasing PEEP to 15 cmH2O reduced the lung O/C only in patients with a higher-PRL
(down to 63±87 gr, P<0.01), and increased the alveolar strain at the same extent in both groups (up
to 0.68±0.33 and 0.84±0.26, respectively, P<0.01 for both). Regardless the same VT (9±2 vs. 9±2
ml/kg) and PEEP (12±3 vs. 11±3 cmH2O) clinically employed, patients with a higher-PRL showed a
greater clinical lung O/C (200±106 vs. 36±26 gr, P<0.01), and a higher mortality rate at ICU discharge
(41 vs. 15%, P=0.02), than patients with a lower-PRL.
CONCLUSION. The use of high level of PEEP appears to be physiologically advantageous only in
patients with a higher-PRL, where the beneficial effects may exceed the harmful ones.
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COMPARISON OF TWO STRATEGIES FOR SETTING PEEP IN ALI/ARDS : EXPRESS
STUDY
Mercat A1, Richard J2, Brochard L3
1Medical ICU, Angers University Hospital, Angers, 2Medical ICU, Charles Nicolle Hospital, Rouen,
3Medical ICU, Henri Mondor Hospital, Cre´teil, France
INTRODUCTION. While the use of PEEP in patients with ALI/ARDS is universally recommended,
the best way for its titration remains unknown.
METHODS. This multicenter randomized controlled trial compared the impact on outcome of two
strategies for setting PEEP in patients with ALI/ARDS. In the “minimal alveolar distension” arm,
PEEP was set for a total PEEP (PEEP + intrinsic PEEP) between 5 and 9 cm H2O. In the “maximal
alveolar recruitment” arm, PEEP was set for a plateau pressure between 28 and 30 cm H2O. A tidal
volume of 6 ml/kg PBW was used in the two arms. The goals for arterial oxygenation and PaCO2 were
the same in the two arms.
RESULTS. The following results were obtained from the first 686 patients: Age 60 ± 15, SAPS II
51.5 ± 17.7, ODIN score 3.1 ± 1.2 , PaO2/FiO2 144 ± 57.
TABLE 1.













VT (ml/kg PBW) 6.1 ± 0.4 6.1 ± 0.3 6.1 ± 0.4 6.2 ± 0.5
PEEP (cmH2O) 7.1 ± 1.8 6.7 ± 1.8 14.7 ± 3.1 13.3 ± 4.8
PEEPtot (cmH2O) 8.4 ± 1.8 8.1 ± 1.9 15.8 ± 2.9 15.1 ± 4.4
Pplateau (cmH2O) 21.1 ± 4.7 20.7 ± 5.1 27.4 ± 2.4 26.4 ± 4.2
RR (c/min) 28 ± 5 28 ± 6 28 ± 5 28 ± 6
PaCO2 (mmHg) 44 ± 10 43 ± 10 44 ± 8 43 ± 9
PaO2/FIO2 149 ± 70 175 ± 81 220 ± 97 246 ± 98
CONCLUSION. The enrolment was stopped after 767 inclusions for non significant difference in
the death rate at day 28: 31.2% in the “minimal alveolar distension” arm and 27.5% in the “maximal
alveolar recruitment” arm. Despite higher values of plateau pressure, no increase in side effects (baro-
trauma,. . . ) was observed in the high PEEP arm.
In patients receiving a tidal volume of 6 ml/kg PBW, a strategy aimed to set PEEP for improving
alveolar recruitment did not result in a statistically significant improvement of survival compared to a
strategy aimed to minimize alveolar distension. Further analyses are underway.
Grant acknowledgement. PHRC national (French Ministry of Health) and research grant from AN-
TADIR
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DETECTION OF CYCLIC ALVEOLAR COLLAPSE BY ELECTRIC IMPEDANCE
TOMOGRAPHY
Muders T1, Wrigge H1, Zinserling J1, Varelmann D1, Hedenstierna G2, Putensen C1
1Dep. of Anesthesiology and Intensive Care Medicine, University of Bonn, Bonn, Germany, 2Dep. of
Clinical Physiology, University of Uppsala, Uppsala, Sweden
INTRODUCTION. Cyclic alveolar collapse and opening (tidal alveolar recruitment) during mechani-
cal ventilation is considered a major risk factor for development of ventilation associated lung injury in
ALI (1). Electric impedance tomography (EIT) has been validated for bedside monitoring of regional
ventilation (2). We studied the hypothesis, that tidal alveolar recruitment can be detected by EIT and
described using a simple index in both direct and indirect experimental ALI.
METHODS. After randomization 10 pigs were tracheotomized and mechanically ventilated with Air-
way Pressure Release Ventilation (APRV). Direct or indirect ALI was induced either by acid aspiration
or by abdominal hypertension in combination with oleic acid injections. After four hours of mechanical
ventilation, a dynamic computed tomography (CT) scan and EIT (esf, Goettingen, Germany, resolu-
tion of 13 Hz) were obtained simultaneously in a transversal thoracic plane during a low flow inflation
maneuver. The amount of recruited lung volume was measured by CT densitometry in four equivalent
quadrants. Impedance changes of these quadrants were plotted over time. Regional curves were ana-
lyzed using several different indices determined by mathematical curve analysis addressing either slope
convexity or concavity, exponent of fitted curve, area under curve (AUC) ratio of real versus expected
AUC assuming a linear slope, or regional time delay until the slope reaches a 5 (RTD5%) or 10%
(RTD10%) threshold. Indices were correlated with amount of recruited volume for each corresponding
region.
RESULTS. The indices AUC ratio (r2=0.14) and regional time delay (RTD5%: r2=0.41 and RTD10%:
r2=0.54) showed a significant correlation with amount of recruited volume.
CONCLUSION. Cyclic alveolar collapse (tidal alveolar recruitment) can be detected and described by
EIT during low flow inflation maneuvers. Time delay in regional impedance changes (RTD) correlated
best with tidal recruitment and appears to be a simple index for clinical bedside monitoring to avoid
risk factors for ventilation associated lung injury.
REFERENCE(S). 1.) Lionetti V, Recchia F A, and Ranieri V M. Overview of ventilator-induced lung
injury mechanisms. Curr. Opin. Crit Care 2005;11:82-86.
2.) Victorino J A and others. Imbalances in regional lung ventilation: a validation study on electrical
impedance tomography. Am. J. Respir. Crit Care Med. 2004;169:791-800.
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EFFECTS OF XIGRIS® ON PULMONARY BLOOD FLOW AND LUNG VOLUME IN
ACUTE LUNG INJURY. A PET STUDY
Richard J1, Bregeon F2, Leray V1, LeBars D3, Costes N4, Tourevieille C3, Lavenne F3, Gimenez G3,
Gue´rin C1
1Critical Care Medicine, Hopital Croix Rousse, Lyon, 2EFR, Hopital Nord, Marseille, 3Critical Care
Medicine, 4CERMEP, Hopital Neurologique, Lyon, France
INTRODUCTION. We hypothetized that: 1) in acute lung injury (ALI) Xigris®, by reopening closed
pulmonary vessels, should modify the distribution of pulmonary blood flow (PBF) and 2) this effect
should result in improving oxygenation if PBF was redirected towards areated lung regions.
METHODS. Sixteen female piglets, anesthetized, tracheotomized and mechanically ventilated were
randomly treated by either Xigris® 24 g/kg/h (XG n=8) or placebo (PG n=8) started 30 minutes (C1)
before induction of ALI. ALI was induced by injecting 0.08 ml/kg oleic acid into the right atrium.
Positron Emission Tomography (PET) was used to measure PBF with H215O (1) and aerated lung
volume at mid tidal volume in corresponding transmission scan (2) both on a pixel-by-pixel basis. The
ventral-to-dorsal distribution of PBF and aerated lung volume was determined across 20 iso-voxel bins
over the whole lungs. Arterial blood gas and static compliance of the respiratory system (Cst,rs) were
also determined. The measurements were performed at C1, 110 minutes after oleic acid injection (C2)
and 3 hours after C2 (C3).
RESULTS. The two groups were comparable before treatment at same ventilatory settings (tidal vol-
ume 10 ml/kg, FIO2 1, PEEP 5 cmH2O, respiratory frequency for pH>7.20 in volume-controlled
mode). PaO2 (mean SD) was significantly (p<0.05) lower in XG than PG at C1 (473 129 vs 578 54
mm Hg), C2 (342 138 vs 446 103 mmHg) and C3 (303 171 vs 547 54 mmHg). The same was true
for Cst,rs. PBF redistributed towards dorsal lung regions in XG relative to PG from C1 (black circles),
to C2 (black squares) and C3 (opend circles) but the difference was not significant between the two
groups. The total areated lung volume was not different between XG and PG at any time (10.0 1.5 vs
11.0 2.5 ml/kg of bw at C1, 10.8 2.7 vs 10.9 1.9 ml/kg of bw at C2 and 10.8 3.7 vs 11.1 1.9 ml/kg of
bw at C3). The aerated lung volume was markedly reduced in the dorsal regions at same extend in both
groups after ALI induction.
CONCLUSION. In the context of present experiment, Xigris® was associated with worsened oxy-
genation, neither explained by anterior-to-posterior PBF redistribution, nor by change in aerated lung
volume. A ventilation-perfusion ratio umbalance at a scale lower than PET resolution may be impli-
cated.
REFERENCE(S). 1. J. Nucl Med 2002;43:1063-1072
2. J Nucl Med 2005;46:1375-1383.
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PROGNOSTIC VALUE OF ABDOMINAL PERFUSION PRESSURE AND FLUID BALANCE
DURING MECHANICAL VENTILATION
Van Regenmortel N1, Ferdinande B1, Wijnants J1, Vercauteren R1, Vermeiren G1, Schoonheydt K1,
Dits H1, Malbrain M L N G1
1Intensive Care Unit, ZiekenhuisNetwerk Antwerpen, Campus Stuivenberg, Antwerpen, Belgium
INTRODUCTION. Intraabdominal hypertension (IAH) is an important outcome-predictor (1-2). Ab-
dominal perfusion pressure (APP=MAP-IAP) is a better resuscitation endpoint (3). No prospective
data on IAP and APP is available in pts with Acute Respiratory Failure (ARF).
METHODS. Over a 24 month period pts admitted with ARF were screened for IAH (defined as
IAP>12 mmHg) with the FoleyManometer method (Holtech, Kopenhagen, Denmark). The IAP was
recorded four times daily together with the highest and lowest APP, fluid balance, and SOFA score.
Until now data are collected on 240 patients (mainly medical) and the study will be continued until 350
pts. The major endpoint was ICU mortality. Values are mean±SD. Unpaired student’s t test was used.
RESULTS. BMI was 25.5±6.3, M/F ratio 1/1, age 64.1±16.7, APACHE-II 22±9.7, SAPS-II 51.4±18.
SOFA score on day1 was 9.8±3.7 with 2.1±1 organ failures. IAP on day1 was 10.3±6.2 mmHg,
while APP was 52.9±15.1. On admission, IAH was present in 32.5% and ACS in 2.9%. Mortality
was 48.8%. Outcome didn’t differ between patients with or without IAH on admission. Non-survivors
(closed squares) had a significantly (p<0.05) higher IAP by day 6 (Fig1A), however APP was already
significantly lower from day 2 onwards (Fig1B). There was a significantly more positive daily and
cumulative net fluid balance (Fig1C) in non-survivors. The area under the receiver operating charac-
teristics curves were the best for SOFA (0.76) and APP (0.74).
CONCLUSION. The preliminary results of an ongoing prospective trial, and the first looking at APP
in ARF show that the incidence of IAH is high in ARF. Mortality is also high and in correlation with
severity scores. The persistence of IAH by day 6 or increasing IAP over time was able to discriminate
between survivors and non-survivors. Non-survivors had a significantly lower APP and more positive
fluid balance from day 2 onwards suggesting better discriminative power. Close monitoring of IAP and
especially APP seems warranted in patients with ARF.
REFERENCE(S). (1) Arch Surg. 1999; 134: 1082, (2) Curr Op Crit Care 2004; 10: 132 (3) J Trauma
2000; 49: 621.
Grant acknowledgement. ESICM Chris Stoutenbeek Award 2003
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PROGNOSTIC VALUE OF RELATIVE ADRENAL INSUFFICIENCY IN PATIENTS WITH
SEPSIS ASSOCIATED ARDS
Qiu H1, Liu L1, Yang Y1
1Department of Critical Care Med, Nanjing Zhong-Da hospital, Nanjing, China
INTRODUCTION. A massive inflammatory reaction resulting from systemic cytokine release is the
common pathway underlying multiple organ dysfunction leading to death in patients with ARDS. Ev-
idence today suggest that, the function of adrenal cortex is an important component of compensatory
anti-inflammatory response. This multiple-center study was designed to determine the rate of relative
adrenal insufficiency (AI) in patients with sepsis associated ARDS and evaluate the prognostic value
of AI.
METHODS. Between July 2004 and February 2005, one hundred and fifty five patients with ARDS in
six ICU of teaching hospitals were included in this study. At the onset of ARDS, a short corticotropin
stimulation test was performed in all patients by intravenously injecting 250ug of adrenocorticotrophic
hormone. Blood plasm cortisol concentration was measured by radioimmunoassay immediately be-
fore the test (T0) and 30 (T30) and 60 (T60) minutes afterward. AI was defined as the difference
between T0 and the highest of the T30 and T60 concentrations (Delta Tmax <= 9ug/dl. At the onset of
ARDS, the following variables were recorded: age, sex, APACHE II score, heart rate, respiratory rate,
mean arterial pressure, PaO2/FiO2, arterial pH and lactate, peripheral blood haemoglobin, platelets and
leukocytes concentration and the number of organ system failure. Patients were divided into survivor
and nonsurvivor group according to whether they died within the 28-day period following the onset of
ADRS.
RESULTS. The 28-day mortality was 54.4% and the morbidity of AI was 43.0%. The rate of AI in
nonsurvivor group was markedly higher than that in survivor group (62.8% vs 20.8%, P<0.01). The
28-day mortality in ARDS patiens with AI was significantly higher than those without it (76.5% vs
37.8%, P<0.001). If AI was as a predictor of death, sensitivity was 75.0% and specificity was 62.2%.
APACHE II, the number of organ system failure, leukocytes, lactate and T0 were significantly lower in
survivor group than in nonsurvivor group, and delta Tmax and platelets were markedly higher in sur-
vivor group than in nonsurvivot group (P<0.05). In multivariate analysis, the number of organ system
failure and AI were independent predictors of death.
CONCLUSION. The morbidity of relative adrenal insufficiency is high in patients with sepsis associ-
ated ARDS. Relative adrenal insufficiency has prognostic value for these patients.
REFERENCE(S). 1. Thopson BT. Crit Care Med, 2003, 31:253-257.
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PROGNOSIS IN A POPULATION OVER 80 YEARS OLD SUBMITED TO MECHANICAL
VENTILATION
Carmo Neto E1, Santos L R1, Azambuja P M1, Roderjan C N1, Hatun R M1, Werneck P1, Silva E G O1,
Vanzan A1, Knibel M F1
1Intensive Care Unit, Hospital Sao Lucas, Rio De Janeiro, Brazil
INTRODUCTION. The results of clinical studies evaluating the influence of age in the clinical out-
comes of patients under mechanical ventilation (MV) are conflicting. Some suggest that elder patients
have worse prognosis than those younger, while others deny it. We aimed to compare the prognosis of
patients in invasive ventilation more than 80 years old to those younger.
METHODS. The primary endpoints were mortality and duration of ventilation, while the secondary
were the incidences of ventilation associated pneumonia (VAP) and tracheostomy. For this purpose,
we followed a concurrent cohort of 88 patients (group E over 80 years old, n=45 and group Y of the
younger, n=43) under mechanical ventilation for more than 48 hours and ages 18 to 95 years. The
sample homogeneity was accessed comparing the APACHE II and the first 24 hours SOFA score. Cat-
egorical variables were compared by the chi square test and the continuous variables by the T test.
Potential biases were controlled by multiple linear regression.
RESULTS. The global results for the cohort were 42% (IC=32-52%) for mortality, tracheostomy 43%
(IC=33-54%), VAP incidence of 19.2 cases/1000 days of ventilation and duration of ventilation 14
days ± 11 (IC=12-17). In the groups E and Y, the measured variables were respectively: APACHE II
17 ± 6 (IC=15-19) versus 15 ± 6 (IC=13-17, p=0.06); SOFA 5 ± 3 (IC=4-6) in both groups (p=0.98);
mortality 40% (IC=25-54%) versus 44% (IC=30-59%, p=0.64); duration of ventilation 16 ± 13 days
(IC=12-20) versus 13 ± 9 days (IC=10-16, p=0.21); incidence of VAP 17.73 versus 20.87 cases/1000
days of ventilation (p=0.89) and the incidence of tracheostomy 44% (IC=29-59%) versus 42% (IC=28-
57%, p=0.85). 93% of the patients in group E and 75% of group Y had non-surgical cause of admission
(p=0.025). In the multiple regression model there was no statistically significant impact on mortality
of APACHE II, diagnosis category (clinical versus surgical) or age, only a tendency for direct relation
of VAP with this endpoint (p=0.06).
CONCLUSION. In our otherwise homogeneous population, advanced age was not an independent
predictor of mortality or longer duration of ventilation. Neither the incidence of VAP nor tracheostomy
pointed out any statistically significant difference in the patients over 80 years of age comparing to
those younger.
Grant acknowledgement. REDE ESHO
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MICROCIRCULATORY DYSFUNCTION IN ICU PATIENTS WITH SEPSIS
Renieris P1, Gerovasili V1, Poriazi M1, Loukas T1, Markaki V1, Routsi C1, Roussos C1, Nanas S1
1First Critical Care Department, Medical School, National and Kapodistrian University, Evangelismos
Hospital, Athens, Greece
INTRODUCTION. Microcirculatory impairement in septic patients has long been implicated as a
major causative factor of post-rescucitation multiple organ failure. The aim of the study was to inves-
tigate the microcirculatory alterations in septic patients with different severity of disease with the non
invasive method of Near Infrared Spectroscopy.
METHODS. We studied 39 (25 males/14 females, age 57±21) patients of a general ICU devided in 3
severity groups: SIRS (n=22), Severe Sepsis (n=9) and Septic Shock (n=8). We also studied 66 healthy
volunteers. We used the InSpectra Near Infrared Spectroscopy device to continuously measure tissue
oxygen saturation (StO2) at the thenar muscle before, during, and after a 3-minute occlusion of the
brachial artery via pneumatic cuff. The decrease rate of the StO2 signal during the occlusion period
was used as an index of tissue O2 consumption rate, and the increase rate of the StO2 signal after the
cuff was released was used as an index of reperfusion to assess endothelial reactivity.
RESULTS. Tissue oxygen saturation (StO2, %) was significantly lower in patients with SIRS or Se-
vere Sepsis when compared to healthy volunteers (76±12 vs. 84±6 p=0.001 and 74±14 vs. 84±6
p=0.002 respectively). Oxygen consumption rate (StO2 decrease rate, %/min) was significantly lower
in patients with Severe Sepsis when compared to healthy volunteers or patients with SIRS (15.9±52.4
vs. 31.2±9.1 p<0.001 and 15.9±52.4 vs. 26.5±13.1 p=0.006 respectively). Patients with Septic Shock
also had a significantly lower oxygen consumption rate when compared to healthy volunteers or pa-
tients with SIRS (p<0.001 and p=0.002 respectively. Reperfusion rate (StO2 increase rate, %/min)
was significantly lower in patients with SIRS or Severe Sepsis when compared to healthy volunteers
(342±139 vs. 553±193 p<0.001 and 189±138 vs. 553±193 p<0.001 respectively). Patients with Sep-
tic Shock had significantly lower reperfusion rate when compared to healthy volunteers (p<0.001).
CONCLUSION. The microcirculation of septic patients is severely impaired, and this seems to de-
pend upon severity of disease. Further studies should evaluate the potential role of Near Infrared Spec-
troscopy in guiding therapy and in providing prognostic information in this patient population.
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WHAT FACTORS EXPLAIN THE PROGRESSION OF INFLAMMATORY RESPONSE IN
PATIENTS WITH SEPSIS?
Herrera Melero M1, Aldabo Pallas T1, Jime´nez R1, Ortiz Moyano J1, Ferna´ndez Garcı´a E1, Escoresca
Ortega A1, Ortiz Leyba C1, Garnacho Montero J1
1Intensive Care Unit, Hospital Universitario Virgen del Rocı´o, Sevilla, Spain
INTRODUCTION. Approximately, one half of the patients presenting with sepsis deteriorated to a
more severe stage of the inflammatory response during the subsequent days. This study aims to assess
the factors involved in the progression of the inflammatory response in patients admitted to the Hospital
with sepsis.
METHODS. A prospective cohort study including all Caucasian adults (age > 18 yrs) admitted to
the hospital with sepsis. The exclusion criteria were: neutropenia, positive human immunodeficiency
virus serologic results, and pregnancy. Sepsis severity, microbiological information, and clinical vari-
ables were recorded. The worsening of the inflammatory response was monitored by two methods: 1)
the rate of patients admitted to the hospital with sepsis who developed severe sepsis or septic shock
and the rate patients with severe sepsis at admission who developed septic shock; 2) calculating the
delta-SOFA. The polymorphisms were determined in all patients by polymerase chain reaction, after
obtaining written consent. A multivariate analysis using logistic regression analysis was used to de-
termine variables independently associated with impairment of inflammatory response. The variables
tested for inclusion in the model had an entry level p < 0.10 in the bivariate analysis.
RESULTS. A group of 224 patients was enrolled in the present study. At the admission to the hospital,
clinical picture of sepsis was present in 78 cases (34.8%), severe sepsis in 85 (38%), and septic shock
in 61 (27.2%). Twenty patients who were admitted with sepsis developed severe sepsis or septic shock
and 37 patients with severe sepsis developed septic shock. Multivariate analysis identified three vari-
ables independently associated with impairment of the inflammatory response: APACHE II score (OR
1.17; 95% CI 1.05-1.29), positive blood culture (OR 2.8; 95% CI 1.05-7.7), and delay of initiation of
adequate antibiotic therapy (OR 1.14; 95% CI 1.06-1.24). Delta SOFA correlated significantly with the
delay of initiation of adequate antibiotic therapy (p<0.0001). By the multiple lineal regression, the only
independent predictor of an increase in SOFA score was the delay of initiation of adequate antibiotic
therapy (p<0.05).
CONCLUSION. There is no significant association among polymorphisms of TNF and IL-10 and
the worsening of inflammatory response. The delay of initiation of adequate antibiotic therapy was an
independent predictor of impairment of inflammatory response.
Grant acknowledgement. Grant (35/01) of the Regional Goverment of Andalucia
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IMPORTANCE OF EARLY ADEQUATE ANTIBIOTIC THERAPY IN PATIENTS ADMIT-
TED TO THE HOSPITAL WITH SEPSIS
Aldabo-Pallas T T1, Herrera Melero M M C1, Garnacho Montero C C2, Jime´nez Barro M M1,
Dı´az A A1, Ma´rquez Va´caro J J A1, Ortiz Leyba C C1, Garnacho Montero J J1
1Intensive Care Unit, Hospital Universitario Virgen del Rocio, Seville, Spain, 2Institute for
Environmental Medicine, University of Pennsylvania, Philadelphia, United States
INTRODUCTION. Genetic variations could influence outcome in patients with sepsis. Recent stud-
ies have showed no association between polymorphisms and mortality. This study aims to evaluate the
impact on mortality of three polymorphisms: (-308 TNF-α polymorphism, polymorphism in the first
intron of the TNFβ gene, and 1082 IL-10 polymorphism) after adjusting for confounding variables,
including the delay of adequate antibiotic therapy, in patients admitted to the Hospital with sepsis.
METHODS. A prospective cohort study including all Caucasian adults (age > 18 yrs) admitted to the
hospital with sepsis. The exclusion criteria were: neutropenia, positive human immunodeficiency virus
serologic results, and pregnancy. Sepsis severity, microbiological information, and clinical variables
were recorded. The polymorphisms were determined in all patients by polymerase chain reaction, after
obtaining written consent. A multivariate analysis using logistic regression analysis was used to deter-
mine variables independently associated with mortality in the entire group and only in those patients
fulfilling septic shock criteria. The variables tested for inclusion in the model had an entry level p <
0.10 in the bivariate analysis.
RESULTS. A group of 224 patients was enrolled in the present study. We did not find a significant
association among any of three polymorphisms and mortality. Forty-six patients were hospitalized in
the general ward and 178 patients were admitted to the ICU. Fifty-two patients died in the hospital
(23.2%). All patients had clinical signs of infection but the causal microorganism could not be mi-
crobiologically documented in 66 patients (29.4%). Empirical antibiotic therapy was inadequate in 16
patients (in-hospital mortality 75%). By multivariate logistic regression analysis, only two factors were
independently associated with mortality: APACHE II score (OR 1.18; 95% CI 1.04-1.35), and delay of
initiation adequate antibiotic therapy (OR 1.09; 95% CI 1.04-1.14). In septic shock patients (n=114),
the delay of adequate antibiotic therapy was the only independent predictor of mortality (OR 1.06;
95% CI 1.01-1.10).
CONCLUSION. This study fails to demonstrate a significant association among polymorphisms of
TNF and IL-10 and the outcome of septic patients and reinforces that a prompt and adequate antibiotic
therapy is the cornerstone of therapy in sepsis.
Grant acknowledgement. Grant (35/01) of the Regional Goverment of Andalucia
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CURRENT NUTRITION PRACTICE IN SEPTIC PATIENTS IN GERMANY – RESULTS
FROM THE SEPNET PREVALENCE STUDY
Schmitz G1, Scha¨dler D1, Engel C2, Brunkhorst F M3, Reinhart K3, Scholz J1, Weiler N1, And the
German Competence Network Sepsis SepNet 3
1Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-
Holstein, Campus Kiel, Kiel, 2Institute for Medical Informatics, Statistics and Epidemiology,
University of Leipzig, Leipzig, 3Department of Anaesthesiology and Intensive Care Medicine,
University Hospital Jena, Jena, Germany
INTRODUCTION. The provision of an appropriate nutritional support to septic patients is generally
accepted as part of the standard care in the intensive care unit (ICU). Still, the optimal route of nutrition
is under debate. The aim of this study was to identify the current nutrition support practice in septic
patients in German ICUs.
METHODS. In the “Prevalence of severe sepsis and septic shock in Intensive Care Units in Germany”
study, a prospective observational cross-sectional study, data from 454 ICUs in 310 randomly selected
hospitals in Germany were collected by local one-day visits of trained physicians from SepNet’s 17 re-
gional study centers. Data was evaluated concerning nutrition modalities. Logistic regression analysis
was used to identify predictors for death.
RESULTS. In a total of 415 patients with severe sepsis/septic shock, enteral nutrition was applied to
19.3% of patients whereas 33.7% received only parenteral nutrition. Both parenteral and enteral nutri-
tion was administered to 33.3%, 9.9% were not fed at all. Valid mortality information was available
for 374 patients. In-hospital mortality was similar in the patients receiving only parenteral nutrition
(21.0%) or mixed nutrition (20.3%). In the group enteral nutrition only mortality was 7.5%. By multi-
variate analysis, the APACHE II score (OR=1.07, 95% CI=1.04–1.11), renal dysfunction and parenteral
nutrition (OR=2.28, 95% CI=1.40–3.71) were significant independent predictors for mortality.
CONCLUSION. Parenteral nutrition is still the most common way of nutrition in patients with severe
sepsis in Germany. In contrast, the literature recommends the preferential use of enteral nutrition which
is associated with reduced morbidity. However, an impact on mortality could not be identified so far.
In this study the risk of death was increased in patients receiving only parenteral or mixed nutrition.
Despite the higher APACHE II score in both groups (median score 21 or 18.5, respectively compared
with 16.5 in the enteral group, p<0.01) our results indicate that parenteral nutrition has an important
attributable effect on mortality in septic patients.
Grant acknowledgement. Supported by the German Federal Ministry of Education and Research
(BMBF), Grant No. 01 KI 0106 and Lilly Deutschland GmbH.
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MULTICENTRE AUDIT OF THE USE OF DROTRECOGIN ALFA (ACTIVATED) IN
UNITED KINGDOM CRITICAL CARE UNITS
Rowan K1, Welch C A1, North E1, Harrison D A1
1ICNARC, Intensive Care National Audit and Research Centre, London, United Kingdom
INTRODUCTION. Following positive results of the PROWESS randomised controlled trial [1],
drotrecogin alfa (activated) received a European licence in 2002. Shortly after, the Intensive Care
National Audit & Research Centre (ICNARC) began an audit to monitor diffusion into routine
practice in the United Kingdom. We present a descriptive analysis of patients receiving drotrecogin
alfa (activated) compared with patients in PROWESS and the open label study ENHANCE [2].
METHODS. In total, 119 adult intensive care units (ICUs) in England, Wales and Northern Ireland
participate in the audit. Data are collected on every patient in whom an infusion of drotrecogin alfa
(activated) is commenced, in three sections: infusion - timing, interruptions and incomplete infusions;
infection - site, organisms cultured, and primary pathogen; and adverse events. These data are linked
to the Case Mix Programme, the national comparative audit of patient outcome, for case mix and
outcomes.
RESULTS. At the time of analysis, data were available on 1245 patients receiving drotrecogin alfa (ac-
tivated) in 99 ICUs. Table 1 shows a comparison of the patients in this study with those in PROWESS
and ENHANCE. The median (quartiles) time from ICU admission to the start of the infusion was 20
(11-35) hours. Twenty-four percent of infusions were interrupted, the most common reasons being in-
sertion, change or removal of lines, cannulas, drains etc (50%), transfer to theatre (15%), and possible
bleeding (12%). The median (quartiles) duration of interruption was 5 (3-10) hours. Thirty percent
of infusions were not completed, the most common reasons being patient deteriorated/died (49%),
possible bleeding (24%), and patient improved/left the unit (10%). Table 2 shows the adverse events
compared with PROWESS and ENHANCE.
TABLE 1.
Comparison of patients in the ICNARC audit with PROWESS and ENHANCE
ICNARC audit PROWESS ENHANCE
Number of patients 1245 850 2378
Age (years), mean (SD) 58.5 (16.2) 60.5 (17.2) 59.1 (16.9)
Male, % 50.0 56.1 58.2
Ventilated, % 90.5 73.3 82.0
Two or more OD, % 94.9 74.6 84.4
SD standard deviation; OD organ dysfunctions
TABLE 2.
Comparison of serious adverse events in the ICNARC audit with PROWESS and ENHANCE
ICNARC audit PROWESS ENHANCE
Any adverse event, n (%) 83 (6.7) 106 (12.5) Not reported
Bleeding event, n (%) 57 (4.6) 30 (3.5) 155 (6.5)
Thrombotic event, n (%) 8 (0.6) 17 (2.0) Not reported
CONCLUSION. Patients in the ICNARC audit of drotrecogin alfa (activated) were more likely to be
mechanically ventilated and had more organ dysfunctions than those in PROWESS or ENHANCE.
The rate of serious bleeding events was higher than in PROWESS but lower than in ENHANCE.
REFERENCE(S). 1. Bernard G R et al. N Engl J Med 2001; 344:699-709.
2. Vincent J L et al. Crit Care Med 2005; 33:2266-77.
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ABRUPT WITHDRAWAL OF PROPHYLACTIC HEPARIN IN SEVERE SEPSIS: POSSIBLE
REBOUND THROMBOSIS
Levi M1, Levy M2, Williams M3, Janes J3, Wang D3, Macias W3
1Internal Medicine, Amsterdam Medical Center, Amsterdam, Netherlands, 2Pulmonary Critical Care,
Brown, Providence, 3Lilly Research Laboratories, Eli Lilly, Indianapolis, United States
INTRODUCTION. The XPRESS study was a large phase 3B study designed to assess whether there
was a true negative interaction with coadministration of Drotrecogin alfa activated (DAA) and low-
dose heparin. We prospectively planned subgroup analyses to examine mortality and serious adverse
events in patients with or without baseline heparin due to recent reports of rebound thrombosis after
heparin cessation.
METHODS. From December 2002 to July 2005, adult patients with severe sepsis at high risk of death
were enrolled in a randomized, double-blind, parallel, placebo-controlled study conducted at 224 cen-
ters in 20 countries. DAA (Xigris®, Eli Lilly and Company, Indianapolis, IN) at 24 mcg/kilogram/hour
for a planned 96 hour infusion was administered to each patient. The study drug was either unfraction-
ated heparin (5000 units subcutaneously twice a day), enoxaparin (40 mg subcutaneously per day)
or placebo in a 1:1:2 randomization scheme. To enhance patient safety, all patients who were receiv-
ing commercial heparin at baseline for any indication were required to stop heparin during the DAA
infusion. 28-day mortality and serious adverse events were analyzed.
RESULTS. A total of 1994 patients received DAA, but only 1935 patients received study drug and
make up the intention to treat (ITT) population. A total of 990 patients were randomized to placebo
and 1004 to heparin (493 to low molecular weight heparin and 511 to unfractionated heparin). An
important treatment-by-subgroup interaction was noted in the subgroup defined by exposure to com-
mercial heparin at baseline, Breslow Day p = 0.03. Among patients who were exposed to commercial
heparin at baseline, higher mortality and serious adverse events were observed in placebo patients
compared with heparin patients, 35.6% versus 26.9% and 18.0% versus 11.6%, respectively. However,
heparin and placebo patients who were not exposed to heparin at baseline had similar mortality and
serious adverse events.
CONCLUSION. Patients who were exposed to commercial heparin at baseline had higher mortality
and serious adverse events in the placebo versus the heparin group. These data suggest that, in patients
with severe sepsis, prophylactic heparin should not be abruptly discontinued unless risk outweighs
benefit.
Grant acknowledgement. The XPRESS study was funded by Eli Lilly and Company.
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THE COST OF SEVERE ALBUMIN SEPSIS TREATMENT (COASST) STUDY.
Guidet B1, Jasso-Mosqueda G2, Priol G3, Aergerter P4
1Intensive Care, Hoˆpital Saint Antoine, Paris, 2Economic, AREMIS consultant, Neuilly sur seine,
3Economic, AREMIS consultant, Neuilly-sur -seine, 4Medical data processing, Hoˆpital Ambroise Pare´,
Paris, France
INTRODUCTION. The use of albumin for the treatment of severe sepsis remains controversial. The
SAFE study (NEJM 2004, 350: 2247) reported a mortality rate of 35.2% in the group resuscitated
with saline compared to 30.7% in the group that received albumin (relative risk 0.74, p = 0.09). This
potential beneficial effect could be explained by several properties of albumin. Despite existing recom-
mendations, albumin remains largely underused in this indication. Given its higher cost compared with
other volume expansion products, modelling of its cost/efficacy ratio would be justified in the light of
the product’s potential advantages.
METHODS. Routine medical practice was compared with the systematic use of albumin. The study
population was defined as all adult patients having been treating for severe sepsis in one of the 35 units
in the CUB-Rea database between 1 January 1998 and 1 December 2002, excluding burn patients,
patients with mediastinis, organ transplant recipients and those having received extracorporeal circula-
tion. Only hospital stays longer than 24 hours and including at least circulatory, kidney or respiratory
failure were considered. Two efficacy indicators were used: the number of lives saved and the number
of years of life gained, using the 4.6% reduction in mortality as the baseline case in the albumin arm of
the SAFE study: Albumin costs were estimated according to the quantities administered in this same
study i.e. 2.24 L. Life expectancy was determined using the DEALE method, with the following factors
into account: age, sex, SAPS II score and Mac-Cabe score.
RESULTS. There were 5980 intensive care deaths according to the CUB-Rea database. The use of al-
bumin induced a 4.6% reduction in the number of deaths (512 lives saved amongst the 11137 patients
included in the study). The mean survival of the 5156 patients discharged alive from the hospital was
estimated at 9.78 years [95%CI: 9.64-9.92]. The average cost of albumin administration per patient
was evaluated at 278.10 e. The cost per life saved was 6073 e and per year of life saved was 617 e.
CONCLUSION. Our results provide strong evidence for a very favourable cost effectiveness ratio of




LONG TERM HEALTH-RELATED QUALITY OF LIFE AFTER CARDIAC SURGERY
Bral E1, Ingels C M M1, Milants I1, Wouters P J1, Van den Berghe G1
1Intensive Care Medicine, University Hospital Gasthuisberg, Catholic University of Leuven, Leuven,
Belgium
INTRODUCTION. In this follow up study, we document the impact of intensive insulin therapy on
long term mortality and objective and subjective well-being of high risk cardiac surgical patients.
METHODS. 4 years after ICU-admission, we assessed long term outcome of the subgroup of car-
diac surgical patients (N=970) included in the original insulin trial (1). Patients or next of kin, or if
unavailable the referring physician, were contacted by phone call. Some data were collected from the
hospital database or the civil registration services. We studied the perceived health-related quality of
life (QoL) using the validated Dutch version of the Nottingham Health Profile (NHP) (2), and the
functional capacity with the Karnofsky Index.
RESULTS. 4 years after ICU, the number of post-hospital-discharge deaths was similar in the conven-
tional treatment group (RIS) and in the intensive insuline treatment group (IIS), reflecting maintenance
of the acute survival benefit with insulin. For the long-stay patients (>3d ICU), 4y-mortality was re-
duced from 36.2% (RIS) to 23.1% (IIS) (p=0.03). Karnofsky scores were available for 78% (N=753) of
the patients (372/381). More than 80% of the patients reached a Karnofsky Index of >60%, indicating
functional autonomy. 603 (303/300) patients provided answers to part 1 of the NHP, 403 (197/205)
answered part 2 of the questionnaire. For part 1, there was no difference between both groups. The
dimensions mostly affected by critical illness were “sleep” and “physical mobility”. For the second
part, “long stay” patients in the IIS had worse scores in the dimensions concerning household activities
(p=0.03), social (p=0.04) and family (p=0.06) life.
CONCLUSION. The short-term survival benefit of intensive insulin therapy (1) was maintained after
4 years. The increased survival of sicker, “long stay” patients, was accompanied with a more compro-
mised subjective QoL. The objective, functional capacity, however was similar in both groups.
REFERENCE(S). (1) Van den Berghe G et al. N Engl J Med 2001; 345: 1359-1367
(2) Erdman R et al. Psychological Reports 1993;72:1027-1035.
Grant acknowledgement. Fund for scientific research Flanders, Belgium and Research fund of the
Catholic University Leuven.
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SURVIVAL, MORBIDITY & QUALITY OF LIFE OUTCOME 18 MONTHS AFTER ICU
Fildissis G1, Zidianakis V1, Tsigou E1, Kouledi D1, Economou A1, Baltopoulos G1
1ICU, Athens University, Faculty of Nursing, Athens, Greece
INTRODUCTION. Assessment of mortality and Health-related Quality of Life (HRQL) are now ac-
cepted as relevant measures of ICU outcome. HRQL measures provide a holistic measure of the impact
of critical illness on the patient (pt). The aim of this study was to analyze the QL of ICU pts before
their ICU admission & 18 months after & its relation to age, gender, length of ICU stay & severity of
illness.
METHODS. Prospective observational study conducted in a 7-bed university mixed ICU in Athens,
GR. All consecutive pts admitted to the ICU for 2 yrs, aged >18 yrs old and stayed >24 hrs were
eligible. Demographic data were collected prospectively on all pts and included age, gender, admis-
sion diagnosis, length of ICU stay (LOS), illness severity (APACHE II), mortality & death probability.
Primary outcomes included survival & HRQL. Data are expressed as X±SEM. Comparisons were
preformed using Paired t-test.
RESULTS. During the 2 yrs study period there were 263 eligible admissions to the ICU; 184
men (70%) & 79 women (30%). Age was 58.18±21 yrs, LOS 15.28±1.41 days, APACHE II
score 17.52±0.48 & PaO2/FiO2 ratio 235.8±9.34. Overall survival was 58.9% (155/263). The
ICU mortality rate of the original cohort of 263 patients was 30.4%, and the hospital mortality
was 5%. Cumulative mortality rate was 38.4% at 6 months & 41% at 12 & 18 months after ICU
admission. Death probability was 28±0.01. Age of the 80 ICU non-survivors was 64.56±16.9
yrs, LOS 16.6±2.93 days, APACHE II 24.6±0.6 & PaO2/FiO2 ratio 202±18.3. Age of the 183
ICU survivors was 55.39±1.62 yrs, LOS 14.69±1.58 days, APACHE II 14.42±0.47 & PaO2/FiO2
ratio 249±10.7. HRQL was evaluated for 116 survivors who completed the 18 months follow-up
& responded to the questionnaire. Pre-ICU QOL score was 2.89. Follow-up revealed significant
improvement in the overall QOL score from 6 (7.0) to 18 months (5.57) (p=0.0001). The subscales
basic physiological activities, BPA (p=0.0025), normal daily activities, NDA (p<0.0001) & emotional
state, ES (p=0.0001) showed a significant deterioration 6 months after ICU admission. A significant
improvement was noted for all the subscales (BPA, p=0.019, NDA & ES, p<0.0001) from 6 to 18
months.
CONCLUSION. When evaluating the long-term outcome of ICU patients, the timing of QL assess-
ment is essential. This study has shown that preadmission QL in our medical-surgical pts was substan-
tially reduced after ICU discharge. Eighteen months after admission to the general ICU most survivors
had regained most of their preadmission QL status. Their PaO2/FiO2 ratio was significantly higher
than in the non-survivors.
REFERENCE(S). 1. Fernandez RR, et all. Intensive Care Med 1996;22:1034-42. 2. Kaarlola A et al.
Intensive Care Med 2003;29:1294-99.
Grant acknowledgement. The Greek Ministry of Health-Central Research Council partly granted this
study.
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ASSESSMENT OF SURVIVAL AND QUALITY OF LIFE IN OCTOGENARIAN 1-YEAR AF-
TER CARDIAC SURGERY
Ledoux D1, Piret S1, Canivet J1, Damas P1
1Intensive Care, Lie`ge University Hospital, Lie`ge, Belgium
INTRODUCTION. There is a growing number of heart surgery procedures performed in octogenar-
ians. However, the benefit for the patient of such procedures may be questionable. In this work, we
analysed 1-year survival and quality of life in octogenarian patients operated for heart surgery.
METHODS. From April 2003 to January 2004, all consecutive patients were prospectively included
in the protocol. We collected data on preoperative comorbidities, surgical procedures characteristics,
postoperative complications and hospital outcome. One-year after surgery, survival was obtained via
patients’ general practitioner. Patients were then interviewed and asked to complete the EuroQOL
questionnaire (1). Data were analysed using chi-square test and Mann Whitney test. A Cox model was
used for survival analysis. A p-value < 0.05 was considered as significant.
RESULTS. Over a 10-month period, 498 patients were included in the protocol. Among them, 44
(8.8%) patients were octogenarian. During the 1-year follow-up, 44 (8.8%) patients died. There were
5 (11.4%) death in octogenarian patients and 39 (8.6%) in younger patients (p=574). The EuroQOL
questionnaire was completed for 426 (94% of survivors) patients. Table 1 gives, for each variable of
the EuroQOL, the percentage of patients with no problem. These results show that while octogenarian
patients have mobility limitations and difficulties with their self-care they do not complain of major
limitation in their usual activities. Moreover octogenarian patients do not suffer more from pain or
depression. When self-reporting their current health status on a scale from 0 to 100, octogenarian pa-
tients rated a significantly lower health status as compared with younger patients ( 62.0 ± 14.8 vs
71.5 ± 15.8, p = 0.001). However, the proportion of patients who considered their health improved as
compared with their preoperative status was similar in both groups ( 62.5% vs 67.7%, p = 0.547). The
univariate Cox model revealed that being octogenarian did not significantly increased the risk of fatal
event during the 1-year follow-up (OR 1.377 95%CI: 0.953-4.428, p=0.501).
TABLE 1.
< 80 years >= 80 years p-value
Mobility 75.3 57.6 0.011
Self-care 92.4 78.8 0.029
Usual activities 78.9 75.7 0.354
Pain/Discomfort 55.7 60.6 0.082
Anxiety/Depression 66.7 60.6 0.521
CONCLUSION. These results are consistent with previous reports (2) suggesting that cardiac surgery
is worthwhile in octogenarian patients.
REFERENCE(S). 1. EuroQol–a new facility for the measurement of health-related quality of life. The
EuroQol Group. Health Policy 1990;16:199-208.
2. Avery G J, 2nd, Ley S J, Hill J D, Hershon J J, Dick S E. Cardiac surgery in the octogenarian:
evaluation of risk, cost, and outcome. Ann Thorac Surg 2001;71:591-6.
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OCTAGENARIAN OUTCOME 12 MONTHS AFTER CRITICAL CARE DISCHARGE
Mason N1, Short A1, Parry-Jones A J1
1Intensive Care, University Hospital of Wales, Cardiff, United Kingdom
INTRODUCTION. In developed countries, the 21st century will see an exponential increase in the
elderly population. Octagenarians are already increasingly referred for Critical Care when our medical
and surgical colleagues perceive the need. Differentiation between those who will benefit from Critical
Care, and those in whom we will only delay death, is difficult. Death after ICU stay is rarely stud-
ied, but, particularly in the elderly, should also contribute to the decision to submit them to Intensive
Therapy.
METHODS. We prospectively collected demographic and survival data on patients >80y admitted to
our Intensive Care in 2002, and followed up for 12 months. Survival to ICU discharge, hospital dis-
charge, and 12 months post ICU discharge, was determined. Age, sex, APACHE II scores, and length
of ICU stay (LOS) were compared for survivors and non-survivors. APACHE II scores were compared
by student t-test for survivors and non-survivors. Equal variance was assumed for APACHE II scores.
Logistic regression analysis was performed for ICU and hospital discharge and for survival at 1 year.
RESULTS. Twenty eight patients (52.8%) survived to ICU discharge, 20 (37.7%) to hospital dis-
charge and 15(28.8%) were alive at 12months. Median age was 82y (range 80-94), mean APACHE II
19.2 (95% CI 17.3 to 21.0; SD 6.8). Median LOS 2days (range 0.5-25). APACHE II scores were signif-
icantly different for ICU survivors, 16.7 vs 21.9 (p=0.004), hospital survivors 15.5 vs 21.4 (p=0.001),
and survivors at 12 months post ICU discharge, 15.2 vs 20.7 (p=0.006). There was no correlation
between age, APACHE II score and LOS. APACHE II score was the only independent predictor of sur-
vival to ICU discharge, hospital discharge and survival at 1 year. LOS was inversely related to survuval
to ICU discharge.
CONCLUSION. The 21st century will see Intensive Care Physicians, and societies at large, having
increasingly difficult ethical and financial decisions regarding the care of the elderly. We found that
APACHE II scores were significantly different not just for Intensive Care survival but also for hospital
survival, and survival at 1 year post ICU discharge, whilst age and LOS in ICU were not. Age alone
should not preclude Critical Care. This study may aid decision making regarding admission to Critical
Care in the octagenarian.
0382
LONG-TERM OUTCOME AFTER INTENSIVE CARE FOR BONE MARROW TRANS-
PLANT RECIPIENTS
Scales D C1, Thiruchelvam D2, Kiss A2, Sibbald W J1, Redelmeier D A2
1Critical Care, Sunnybrook Health Sciences Centre, 2Other, Institute for Clinical Evaluative Sciences,
Toronto, Canada
INTRODUCTION. Intensive care unit (ICU) admission for bone marrow transplant recipients during
the early post-transplantation period is associated with poor outcome. Survival of these patients with
ICU admissions during subsequent hospitalizations is unknown. We sought to determine the long-term
outcome of bone marrow transplant recipients who were admitted to ICU during subsequent hospital-
izations.
METHODS. We conducted a population-based retrospective cohort study in Ontario, Canada from
January 1, 1992 to March 31, 2002. All Ontario bone marrow transplantation recipients who received
subsequent ICU care during the study interval were included. The primary outcome was mortality at
one year. We also examined the association of specific ICU procedures on mortality.
RESULTS. A total of 2698 patients received bone marrow transplantation; of which 513 received ICU
care during subsequent hospitalizations. Patients receiving any ICU procedure had higher one-year
mortality (87% vs 44%, p<0.0001). Death rates were highest for those receiving mechanical ventila-
tion (86%), right heart catheterization (91%), or dialysis (94%). In combination, the strongest inde-
pendent predictors of death were mechanical ventilation (HR 7.3; 95% confidence interval 4.2 to 11.2)
and dialysis (HR 9.2; 95% confidence interval 2.2 to 38.6). Regardless, no combination of procedures
uniformly predicted 100% mortality.
CONCLUSION. The prognosis of bone marrow transplant recipients receiving ICU care is very poor,
but should not be considered futile.
REFERENCE(S). 1) Rubenfeld, G. D. and Crawford, S. W. Withdrawing Life Support From Me-
chanically Ventilated Recipients of Bone Marrow Transplants: a Case for Evidence-Based Guidelines.
Annals of Internal Medicine.125(8):625-33, 10-15-1996.
2) Bach, P. B., Schrag, D., Nierman, D. M., Horak, D., White, P., Jr., Young, J. W., and Groeger, J.
S. Identification of Poor Prognostic Features Among Patients Requiring Mechanical Ventilation After
Hematopoietic Stem Cell Transplantation. Blood.98(12):3234-40, 12-1-2001.
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HEALTH RELATED QUALITY OF LIFE 90 DAYS AFTER ICU ADMISSION: A SAPS 3 SUB-
STUDY
Capuzzo M1, Moreno R P2, Jordan B3, Bauer P3, Alvisi R1, Metnitz P G H4
11Dept. of Surgical, Anaesthetic and Radiological Sciences, Service of Anesthesiology and Intensive
C, University Hospital of Ferrara, Ferrara, Italy, 2Unidade de Cuidados Intensivos Polivalente, Hospi-
tal de St. Anto´nio dos Capuchos, Centro Hospitalar de Lisboa Zona Central, Lisboa, Portugal, 3Dept.
of Medical Statistics, 4Dept. of Anesthesiology and General Intensive Care, Medical University of
Vienna, Vienna, Austria
INTRODUCTION. Health-related quality of life (HRQOL) is an indicator of outcome for intensive
care patients. Therefore, a prospectively designed substudy on HRQOL 90 days after ICU admission
was proposed as an additional option to ICUs participating in the SAPS 3 project [1,2].
METHODS. The EuroQol questionnaire (EQ-5D) [3], in the appropriate language version, was admin-
istered to the patients who spent >24 h in ICU and survived for 90 days. A question to compare present
health status with that 3 months before ICU admission (better/same/worse) was added. Nineteen ICUs
(12 located in Italy, 2 in Belgium, and 1 in each of the following countries: Argentina, Austria, Greece,
Hungary, and Slovakia) participated in the present substudy. All data on HRQOL were recorded by us-
ing the SAPS 3 stand-alone database system provided by the Coordination and Communication Centre
of the SAPS 3 project.
RESULTS. Out of the 782 patients with ICU length of stay >24 h admitted to the 19 ICUs and
surviving hospital discharge, 618 were alive, 34 died and 130 lost 90 days after ICU admission. At
follow-up health comparison was available in 559 survivors, being better in 189 (33.8%), the same in
174 (31.1%), and worse in 196 (35.1%).
TABLE 1.











No problems 303 (54.2) 355 (63.5) 262 (46.9) 305 (54.6) 288 (51.5)
Some problems 179 (32.0) 107 (19.1) 166 (29.7) 202 (36.1) 198 (35.4)
Severe problems 76 (13.6) 96 (17.2) 130 (23.3) 51 (9.1) 64 (11.4)
Missing 1 (0.2) 1 (0.2) 1 (0.2) 1 (0.2) 9 (1.6)
CONCLUSION. Early recovery of health status, in comparison with 3 months before ICU admission,
is reported by more than 60% of ICU patients.
REFERENCE(S). 1. Metnitz P G H et al. (2005) Intensive Care Med 31:1336-1344 DOI
10.1007/s00134-005-2762-6
2. Moreno R P et al. (2005) Intensive Care Med 31:1345-1355 DOI 10.1007/s00134-005-2763-5
3. The EuroQol Group. (1990) Health Policy 16:199-208.
Grant acknowledgement. European Society of Intensive Care Medicine (ESICM); Portuguese Soci-
ety of Intensive Care (SPCI); Austrian Centre for Documentation and Quality Assurance in Intensive
Care Medicine (ASDI); iMDsoft Corporation; Fund of the Austrian National Bank, project 10995
ONB.
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FUNCTIONAL OUTCOME AND QUALITY OF LIFE IN ELDERLY PATIENTS AFTER DIS-
CHARGE FROM INTENSIVE CARE
Nicola´s J M1, Lahoz S2, Culla A2, Sacanella E1, Castro P1, Masanes F1, Navarro M2, Lopez-Soto A2
1Medical Intensive Care, 2Geriatric Unit, Hospital Clı´nic, Barcelona, Spain
INTRODUCTION. The aim of the study was to evaluate the functional outcome and perceived quality
of life of elderly patients after non-elective admission to the ICU.
METHODS. We enrolled in a prospective longitudinal study patients admitted to ICU that were older
than 65 years, and evaluated their functional status and quality of life six months after discharge from
the hospital. We excluded patients with a low functional status (Barthel index, BI < 60), those admitted
after elective surgery, those admitted after cardiac arrest and those with a life-expectancy lower than
one year. Daily severity scores (APACHE II, SOFA) and intensity of treatment (OMEGA) on ICU were
recorded. Geriatric assessment included functional (BI), cognitive (Foldstein’s Minimental status test)
and comorbidity (Charlson index) evaluation. Quality of life was evaluated by means of SF-36 and
EuroQOL tests previous to admission and at 3 and 6 months of follow-up.
RESULTS. We studied 130 patients out of 260 admitted. Functional status at hospital discharge was
reduced in two-thirds of the patients (P < 0.001), and partially recovered along follow-up (P < 0.01).
Patients from 65 to 74 years (n = 64) and those older than 75 years (n = 66) had similar APACHE
II, SOFA and OMEGA scores as well as comparable functional status at admittance and hospital dis-
charge (BI: 71 vs 64, respectively). However, patients > 74 years were significantly more dependent at
6-month follow-up whereas functional status in younger had returned to baseline values after 6-month
hospital discharge (BI: 75 vs 91, respectively, P = 0.02). Perceived quality of life was also significantly
lower at hospital discharge than baseline (P < 0.001), remained low at three months of follow-up.
However, the perception of quality of life returned to a level comparable to baseline, after 6 months of
hospital discharge.
CONCLUSION. Functional recovery and perceived quality of life of elderly patients after non-elective
ICU admission is slowly achieved in the following six months after hospital discharge, especially in
those from 65 to 74 years old.
Grant acknowledgement. FIS PI020533 and PI030329.
Oral Presentations
Hot topics in VAP 0385-0391
0385
EXTRA-CHARGES FOR NOSOCOMIAL PNEUMONIA IN EUROPEAN INTENSIVE CARE
UNITS (PRELIMINARY RESULTS OF EU- VAP/CAP STUDY)
Koulenti D1, Carneiro A2, Krueger W3, Diaz E1, Komnos A4, Guven M5, Martin-Mojarro E1, Rello J1
on behalf of the EU-VAP/CAP Study Investigators
1Crit. Care Dep., Joan xxiii Univ. Hospital, Tarragona, Spain, 2ICU, Santo Antonio Hospital, Porto,
Portugal, 3Dep.of Anesthesiology and Intensive Care Med., Tuebingen Univ. Hospital, Tuebingen, Ger-
many, 4ICU, Larisa Gen. Hospital, Larisa, Greece, 5ICU, Erciyes Univ. Hospital, Kayseri, Turkey
INTRODUCTION. Nosocomial pneumonia represents a major health problem and has a significant
impact on the cost of care. The aim of this study was to estimate the extra-charges on health-care added
by nosocomial pneumonia in European Intensive Care Units (ICUs).
METHODS. An observational, prospective, international multi-center study was conducted in Euro-
pean ICUs. Patients that required invasive mechanical ventilation (MV) for >48 hours were included
in the database. A comparison was made regarding the days on MV and the length of stay (LOS) in
ICU between patients with and without nosocomial pneumonia. Statistic analysis was performed using
SPSS11.0.
RESULTS. During the first 3 months of the study 309 consecutive patients were included; 69.6%
(n=215) were men, and the mortality rate was 29.4% (n=91). The 22% (n=68) had nosocomial pneumo-
nia (HAP n=17 and VAP n=51). The MV patients with nosocomial pneumonia (n=68) were compared
with MV patients without pneumonia (n=241). The mean age of patients with nosocomial pneumonia
was lower (49.5±18.7 years versus 57.6±18.1 years, p<0.01), while the mean SAPSII was comparable
(41.2±14.1 versus 40.9±17.0, p>0.20). Nosocomial pneumonia increased the days on MV (14.1±9.4
versus 8.6±10.9, p<0.01), the LOS in ICU (19.7±12.6 versus 11.1±11.9, p<0.01) and the estimated
mean cost of ICU stay (82.740 euros versus 46.620 euros, p<0.01).
CONCLUSION. Nosocomial pneumonia not only leads to a significant increase in length of MV and
ICU LOS, but adds substantially to hospital costs.
Grant acknowledgement. This study was supported in part by FISS PI05/2410, and 2005/SGR920.
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WEEKLY SYSTEMATIC ENDOTRACHEAL ASPIRATION ALLOWS EARLY AND ADE-
QUATE ANTIBIOTIC THERAPY FOR VAP
Jung B1, Jaber S1, Perrigault P1, Sebbane M2, Verzilli D1, Jeanpierre H3, Eledjam J J1
1DARB, CHU Montpellier, Hopital Saint Eloi, 2DARB, CHU Montpellier, Hopital Saint Eloi, 3Service
de bacte´riologie, CHU Montpellier, Hopital Arnaud de Villeneuve, Montpellier, France
INTRODUCTION. Although attributable mortality rate for Ventilator-acquired Pneumonia (VAP) is
still controversial, any delay in adequate antibiotic treatment compromises its outcome. Moreover, VAP
diagnosis and its optimal treatment remains a challenge for the intensivists. We therefore performed
routine weekly endotracheal aspiration (EA) to guide the initial antibiotic treatment before the results
of broncho-alveolar lavage (BAL) for VAP.
METHODS. We prospectively studiedy 113 VAP. We evaluated the concordance between the latest
EA and the BAL and separated patients into three groups: group I: concordant EA-BAL, group II dis-
cordant EA and BAL, group III: no EA. We then compared the ad equation of the initially antibiotic
initially prescribed, the morbidity and the mortality between the three groups.
RESULTS. 90 assessable samples EA-BAL could be were evaluated. The early antibiotic strategy
guided by the EA was adequate in 85% of the situations and was significantly superior to the treatment
recommended by the ATS guidelines (1) (73%) and better than the treatment recommended by the
Trouillet (2) guidelines (81%) but did not reached the significativity. When clinicians could not have a
pre-VAP EA to guide their treatment (group III) only 61% of the treatments were adequate. There was
not any no statistical difference between the three groups for length of mechanical ventilation, length
of ICU stay in ICU, extra-pulmonary nosocomial infections or mortality.
CONCLUSION. Systematic oncee weekly systematic pre-VAP EA allowspermits an adequate early
adequate antibiotic therapy. However, the impact of our strategy, “early and guided by the EA” on
outcome needs to be evaluated prospectively by a randomised clinical trial.
REFERENCE(S). (1): Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, ini-
tial antimicrobial therapy, and preventive strategies. A consensus statement, ATS, November 1995. Am
J Respir Crit Care Med 153(5):1711-25. (2): Trouillet, J. L. and al. 1998. Ventilator-associated pneu-
monia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157(2):531-9. (3):
Michel and coll, early antiobiotic treatment for BAL-copnfimred VAP: a role for routine ebdotracheal
aspirate cultures. Chest 127 (2): 589-97.
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VALUE OF POLY-URETHANE CUFFED ENDOTRACHEAL TUBE IN THE PREVENTION
OF EARLY POST-OPERATIVE PNEUMONIA
De Wolf A1, Blot S1, Vandevelde S2, Depuydt P1, Poelaert J1
1Intensive Care, 2Anesthaesia, University Hospital Ghent, Ghent, Belgium
INTRODUCTION. Cardiac surgery patients are at risk for post-operative pneumonia, with peri-
operative micro-aspiration as a possible cause. We hypothesised that the use of poly-urethane cuffed
endotracheal tubes (PUC tube)(Seal Guard®, Tyco Healthcare, USA) could be protective due to en-
hanced sealing of the pharyngo-tracheal barrier, in comparison with conventional poly-vinyl cuffed
tubes (PVC tube).
METHODS. All patients planned for cardiac surgery during a 100 days period were randomised be-
tween a PVC tube or a PUC tube after informed consent. Patients with preoperative antibiotic therapy,
prior pneumonia or endocarditis were excluded. Diagnosis of early post-operative pneumonia was
based on an infiltrate on chest X-ray, purulent tracheal secretions, fever and leucocytosis or increase
in C-reactive protein serum levels, within 3 days after surgery. Statistical analysis was performed by
means of Chi-square test and Mann Witney U test for categorical and continuous variables respectively.
RESULTS. We included 134 patients with 67 patients in each group. Occurrence rate of co-morbidities
such as diabetes mellitus, COPD, tabagism and chronic kidney failure was equal between the two
groups. There was no difference in type of surgery and peri-operative transfusion need. Patients char-
acteristics are in the table.
TABLE 1.
PUC tube (n=67) PVC tube (n=67) P-value
Age (years) 70 (60-76) 70 (62-76) 0.908
Body Mass Index 27 (24-30) 26 (24-30) 0.427
Ejection fraction (%) 65 (58-78) 70 (47-71) 0.143
EURO score 4 (2-7) 5 (2-7) 0.467
TU score 4 (2-5) 3 (2-6) 0.698
Duration of surgery (min) 240 (206-300) 270 (240-300) 0.203
Duration of postoperative
mech ventilation (hours)
16 (13-20) 17 (13-21) 0.455
Early postoperative
pneumonia
15 (22%) 28 (42%) 0.016
CONCLUSION. Use of a PUC tube significantly decreased the rate of early postoperative pneumonia
in cardiac surgery patients. Further (bacteriological) analysis is necessary to elucidate the link between
micro-aspiration and pneumonia.
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LACK OF ASSOCIATION BETWEEN BED POSITIONING AND VENTILATOR-
ASSOCIATED PNEUMONIA (VAP) OCCURRENCE
Girou E1, Polito A2, Soing-Altrach S1, Boulay A1, Brun-Buisson C2, Brochard L2
1Infection Control Unit, 2Medical Intensive Care Unit, Henri Mondor Hospital, Creteil, France
INTRODUCTION. Placing mechanically ventilated patients in semirecumbent position is recom-
mended to prevent VAP. In one randomized trial, semirecumbent position (45◦) was associated with a
4-fold decrease in VAP rate.(1) However, according to a recent study, this measure seems difficult to
implement. (2) The aim of the study was to assess adherence to this measure in routine practice and its
influence on VAP rates.
METHODS. All intubated and mechanically ventilated patients admitted in 3 French ICUs (one medi-
cal, and 2 surgical) were prospectively followed-up during a 4 month-period. Demographic and clinical
characteristics of patients were collected on admission. Bed positioning and trunk flexion were mea-
sured twice daily until extubation, first episode of VAP or death. In clinically suspected patients, VAP
was ascertained by a positive (≥103 CFU/mL) plugged telescopic catheter culture.
RESULTS. A total of 154 patients ventilated ≥ 48h were enrolled. Median bed angle was 21◦ (in-
terquartile (IQR), 13-27) but actual median patients’ trunk flexion was only 15◦ (IQR, 10-21). Median
bed angle was significantly higher in the medical ICU than in surgical ICUs (25 ◦ vs 15◦, respec-
tively, p>.0001). VAP incidence was 30% overall, 25% in the medical ICU and 36% in surgical ICUs
(p=0.06). VAP were classified as early-onset pneumonia in 20 cases (43%) and late-onset pneumonia
in 27 cases (57%). Potential risk factors for VAP identified in univariate analysis were: ICU admission
for surgical emergency, trauma, high SAPS II score. A bed angle <20 ◦ was found in 49% of patients
with VAP and in 40% of patients without VAP (p=0.32). By logistic regression analysis, only a surgi-
cal emergency reason for admission was independently associated with VAP occurrence (adjusted OR,
1.09; 95%CI, 1.21-5.97). No association could be found with bed angle whatever the value considered.
CONCLUSION. In our setting, elevating the head of the bed at an angle > 30◦ was not achieved on
a routine basis during mechanical ventilation. Despite half of the patients being kept at less than 20◦,
this was not associated with an increased risk of VAP.
REFERENCE(S). (1) Drakulovic MB et al. Lancet 1999;354:1851-8
(2) van Nieuwenhoven CA et al. Crit Care Med 2006;34:559-61.
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VENTILATOR-ASSOCIATED PNEUMONIA IN TRACHEOSTOMIZED PATIENTS
Alcala M1, Lopez-Mendoza D1, Perez-Calvo C1, Mun˜oz-Varea M1, Gamo A1, Perez M1, Ruiz-
Escribano E1, Suarez F1
1Critical Care, Jimenez Diaz-CAPIO Foundation, Madrid, Spain
INTRODUCTION. The presence of tracheostomy is considered a major risk factor to develop
ventilator-associated pneumonia (VAP), but there are not enough studies that have been designed to
address the incidence and density of incidence for this infection, following the NNIS protocol. The
present study was conducted with this end-point.
METHODS. This cohort study has been conducted in a 15-bed adults university multidisciplinary ICU
during the last 13 years, in a prospective way. VAP was defined following the CDC criteria with pos-
itive microbiological confirmation. All refered patients received percutaneous dilational tracheostomy
like Ciaglia technique (PDT). The moment to perform the tracheostomy was chosen by consensus,
once the patient was hemodinamically and respiratory stable and without intracraneal hypertension
crisis. The patients were under general anaesthesia and mechanical ventilation (MV). The variables are
expressed as mean and standard deviation.
RESULTS. We recluted 515 patients, 63% male, 60±15 years old, with APACHE II at admission of
22±4 and 16±3 at the date of the PDT. This series included 52% neurocritical patients. Patients were
24±15 days in ICU [previous (PR) and posterior (PO) to PDT during 12±8 and 13±11 days respec-
tively] and MV in all of its modes was administrated during 21±13 days (11±7 PR and 10±9 PO).
There were 132 episodes of VAP microbiologically addressed (69 PR and 71 PO). Eight patients had












VAP-total 25.63% 25.63% 10.46%o 12.21%o 0.85
VAP-PR 13.39% 13.39% 11.31%o 11.87%o 0.95
VAP-PO 13.78% 13.78% 10.88%o 14.21%o 0.76
CONCLUSION. The incidence of VAP-PO in PDT-patients, as it has been defined in this study, is
similar to VAP-PR but the infection density incidence is clearly superior. The crude incidence of VAP
during all their stay in the ICU is very high compared with NNIS or ENVIN-UCI reports. However,
the incidence of VAP corrected by the adjusted density of infection is online or even slightly inferior
overall, considering the frequency of neurocritical patients in this series.
0390
PNEUMONIA DIAGNOSIS IN EUROPEAN INTENSIVE CARE UNITS (PRELIMINARY RE-
SULTS OF EU-VAP/CAP STUDY)
Koulenti D1, Brun-Buisson C2, Regnier B3, Sole-Violan J4, Topeli A5, Paiva J A6, Macor A7, Rello J1
on behalf of the EU-VAP/CAP Study Investigators
1Crit. Care Dep., Joan xxiii Univ. Hospital, Tarragona, Spain, 2Service de Reanimation Medicale, Henri
Mondor Hospital, Creteil Paris, France, 3ICU, Bichat-Claude Bernard Univ. Hospital, Paris, 4Crit.
Care Dep., Dr Negrin Univ. Hospital, Gran Canarias, Spain, 5ICU, Hacettepe Univ. Hospital, Ankara,
Turkey, 6Crit. Care Dep., S. Joao Hospital, Porto, Portugal, 7Preven. Rischio Infettivo, A. Savoia Hos-
pital, Torino, Italy
INTRODUCTION. The aim of this study was to describe the techniques used in European Intensive
Care Units (ICUs) for the diagnosis of pneumonia.
METHODS. An observational, prospective, international multi-center study was conducted in Eu-
ropean ICUs. During the first 3 months of the study 309 consecutive patients that required invasive
mechanical ventilation (MV) for >48 hours were included in the database. Statistic analysis was per-
formed using SPSS11.0.
RESULTS. The patients’ mean age was 55.8 ±18.5, 69.6% (n=215) were men, mean admission’
SAPSII was 40.1±16.4, mean days on MV was 9.8±10.8, mean LOS in ICU was 13.0±12.6, and the
mortality rate was 29.4% (n=91). The 34% (n=105) of the patients included in the study were admit-
ted with or developed pneumonia: 12% (n=37) CAP, 5.5% (n=17) HAP, and 16.5% (n=51) VAP. The
diagnostic techniques used are shown in the table:
TABLE 1.







CAP 37 (12%) 37.8% (n=14) 18.9%(n=7) 43.2%(n=16) 27%(n=10) 24.3%(n=9)
HAP 17 (5.5%) 35.3% (n=6) 52.9%(n=9) 58.8%(n=10) 23.5%(n=4) 11.8%(n=2)
VAP 51 (16.5%) 11.8% (n=6) 29.4%(n=15) 84.3%(n=43) 11.8%(n=6) 9.8%(n=5)
Total 105 (34%)
CONCLUSION. The etiological diagnosis of severe pneumonia in European ICUs is based mainly on
non-invasive techniques.
Grant acknowledgement. This study was supported in part by PI05/2410FISS, and 2005/SGR920.
0391
CLINICAL RESOLUTION PATTERN OF PSEUDOMONAS AERUGINOSA VENTILATOR
ASSOCIATED PNEUMONIA
Planas K1, Vidaur L1, Sierra R2, Diaz E1, Rello J1
1Intensive Care Unit, Joan XXIII University Hospital, Tarragona, 2Intensive Care Unit, Hospital Puerta
del Mar, Cadiz, Spain
INTRODUCTION. Our objective is to evaluate the clinical resolution pattern in ventilator associated
pneumonia (VAP) due to Pseudomonas aeruginosa (PA) and establish the influence of inadecuacy of
empirical antibiotic therapy in the evolution.
METHODS. Prospective observational multicenter study on intubated patients with clinical suspicion
of VAP. Incluison criteria included episodes of VAP due to PA. Clinical variables of resolutions were
collected daily as reported elsewhere1. “Failure to resolve pneumonia” was defined as the lack of reso-
lution of at least two clinical variables during the first 72 hours after VAP onset. Appropriate antibiotic
therapy was defined by the presence of at least one active agent against PA.
RESULTS. One hundred and seventy-two episodes of VAP were admitted during the study period.
Fourty-two of them were due to PA and were included in the study. Twelve (28%) patients received
adequate initial antibiotic therapy. Patients with adequate therapy were older than patients with initial
inadequate antibiotic therapy (41.4±21.1 vs 60.5±16.6; p<0.01) but the APACHE II at admission was
the same in both groups (21 vs 18’4; p=ns). Mean stay in the ICU and the time of mechanical ventila-
tion was also the same in both groups.
After 48 hours of antibiotic therapy, defervescence was observed in 83% of patients with adequate
compared to 13% of patients with inadequate empirical antibiotic therapy (p=0.0001). Clinical reso-
lution of hypoxemia was also different in the patients with adequate and inadequate antibiotic therapy
(75% vs 30%; p<0.01). The rate of failure to improve was higher in patients with inadequate empirical
antibiotic therapy (83.3% vs 13.3%; p<0.05). Length of antibiotic therapy was also longer in the group
of patients with inadequate therapy (13.7±5.8 vs 24.2±13.2; p<0.05).
CONCLUSION. Pseudomonas aeruginosa VAP resolves during the first 48 hours of adequate therapy.
Inadequacy of initial antibiotic therapy is the only modifiable factor which influence clinical resolution
of VAP due to Pseudomonas aeruginosa.
REFERENCE(S). Vidaur L, Gualis B, Rodriguez L et al. Clinical resolution in patients with suspi-
cion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute
respiratory distress syndrome. Crit Care Med. 2005; 33: 1248-53.
Grant acknowledgement. Supported by SGR/05920; FIS 05/2410 and FIS 04/1500.
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CAN TISSUE DOPPLER IMAGING BE USED TO DIAGNOSE WEANING-INDUCED PUL-
MONARY EDEMA?
Lamia B1, Ochagavia A1, Chemla D2, Osman D1, Richard C1, Teboul J L1
1Service de re´animation me´dicale, EA4046, 2Service d’explorations fonctionnelles, EA 4046, CHU de
Biceˆtre, Universite´ Paris-Sud 11, Le Kremlin Biceˆtre, France
INTRODUCTION. Weaning-induced pulmonary edema is a classical cause of failure of weaning
from mechanical ventilation in high risk patients (COPD and chronic left heart disease). The diagnosis
may require pulmonary artery catheterization, showing increased pulmonary artery occlusion pressure
(PAOP) during the weaning trial. Among the numerous transthoracic echocardiography parameters in
mechanically ventilated patients, the best estimate of PAOP is E/Ea, which is the ratio of the protodi-
astolic mitral velocity (E) to the early diastolic velocity of the mitral annulus (Ea), obtained by using
tissue Doppler imaging.
The aim of our study was to test the hypothesis that the E/Ea ratio could be used to detect weaning-
induced pulmonary edema defined by intolerance to spontaneous breathing (SB) and increase in PAOP
above 18 mmHg during the weaning trial.
METHODS. Sixteen patients who failed two consecutive weaning trials and in whom insertion of a
pulmonary artery catheter was decided by the attending physician entered the study. In all patients, a
weaning trial was performed over a maximum 1-h period of SB using a T-piece. At baseline and during
the weaning trial, end-expiratory PAOP and E/Ea were measured.
RESULTS. Overall (32 simultaneous measurements) E/Ea correlated with PAOP (r2=0.26, p=0.003).
From baseline to the end of the weaning period, PAOP increased from 11 ± 4 mmHg to 19 ± 6 mmHg
(p<0.001) and E/Ea increased from 9 ± 2 to 12 ± 4 (p<0.001). During the weaning trial, the increase
in PAOP and the increase in E/Ea strongly correlated (r2=0.59, p<0.001). In patients (n=8) who experi-
enced weaning-induced pulmonary edema, PAOP increased significantly from 10 ± 4 mmHg to 23 ± 5
mmHg (p<0.001) and E/Ea from 8 ± 2 to 13 ± 4, (p<0.05). In patients (n=8) without weaning-induced
pulmonary edema PAOP did not significantly increase (from 12 ± 6 mmHg to 14 ± 4 mmHg, p=0.06)
whereas E/Ea significantly increased from 9 ± 2 to 11 ± 3 (p=0.03). The best threshold value of E/Ea
allowing to detect an increase in PAOP > 18 mmHg, was 10 with a sensitivity of 70% and a specificity
of 73%.
CONCLUSION. The weaning-induced changes in E/Ea measured using tissue Doppler imaging, cor-
related with the weaning-induced changes in PAOP. However, E/Ea did not appear to be reliable enough
for diagnosing weaning induced pulmonary edema.
0393
DO PEEP-INDUCED CHANGES IN CARDIAC OUTPUT INDICATE FLUID RESPONSIVE-
NESS?
Lambert P1, Kjærsgaard Hansen L1, Sloth E2, Smith B W3, Koefoed Nielsen J1, Larsson A L S1
1Anesthesiology and Intensive Care, Aalborg and Aarhus University Hospitals, Aalborg,
2Anesthesiology and Intensive Care, Skejby, ˚Arhus University Hospitals, ˚Arhus, 3MMDS, Aalborg
University, Aalborg, Denmark
INTRODUCTION. It is well known that positive end-expiratory pressure (PEEP) depresses circula-
tion at hypovolemia and that fluid loading could counteract this circulatory impairment. Therefore, in
an animal model of mild hypovolemia, we investigated whether a PEEP challenge might predict fluid
responsiveness. The hypothesis was if PEEP reduces cardiac output (CO), this would indicate fluid
responsiveness at 0 cmH2O PEEP, while on the other hand if PEEP does not reduce CO, this would
indicate that further fluid administration will not improve circulation.
METHODS. 8, 20-22 kg, anesthetized, muscle-relaxed and mechanically ventilated pigs were sub-
jected to 0, 10, and 20 cmH2O of PEEP at 10% (of estimated blood volume) hypovolemia, normov-
olemia, 10% and 20% hypervolemia. Hypovolemia was achieved by venesection and hypervolemia by
infusion of a starch-solution. CO was assessed by Pulse Contour Analysis (PiCCO). Statistics: Kruskal
Wallis and Wilcoxons tests, p<0.025 was considered significant. Median and 25.75% are shown.
RESULTS. CO at 0 cmH2O PEEP increased significantly from hypovolemia to 10% hypervolemia,
while no change in CO at 0 cmH2O PEEP was found between 10% and 20% hypervolemia. At hypov-
olemia and normovolemia, 10 cmH2O PEEP induced a significant decrease in CO (from 2.7 (2.3,3.1)
to 2.1 (1.8, 2.5) L/min and from 3.0 (2.7, 3.4) to 2.3 (2.0,2.7) L/min, respectively), while no change
occurred at 10% and 20% hypervolemia (from 3.1(2.8,3.7) to 3.0(2.8,3.2), and from 3.1(3.4,2.8) to
2.9(3.1,2.8) L/min, respectively) . At 20 cmH20 PEEP CO decreased at all volemic levels.
CONCLUSION. A challenge using a moderate level of PEEP predicted fluid responsiveness in this
model. A PEEP challenge might therefore be an alternative to the dynamic methods for assessing fluid
responsiveness during mechanical ventilation.
Grant acknowledgement. Fund by the Danish Medical Research Council (no. 22-03-0299, 22-04-
0420), The Clinical Institute, Aarhus University (no 100301).
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ROLE OF THE BETA2 ADRENERGIC RECEPTOR IN STIMULATING CARDIAC
INOTROPIC PERFORMANCE
Walton B1, Chow A1, Pearl N1, Penn B2, Agrawal R1, Wong J1, Rosenthal M1, Patterson A J1
1Anesthesia, Stanford University, Stanford, 2Undergraduate School, University of Maryland,
Baltimore, United States
INTRODUCTION. beta1 and beta2 adrenergic receptors (ARs) mediate the primary effects of cat-
echolamines in the mammalian heart. Although structurally similar, these receptor subtypes differ in
some important ways. For example, continuous beta2AR stimulation protects the heart. Continuous
beta1AR activation causes myocardial injury. Previously, the beta2AR was thought to play only a mi-
nor role in the enhancement of cardiac inotropic performance. Our data suggest that this theory may be
incorrect. We found that in the absence of beta2ARs, cardiac contractility was significantly impaired.
METHODS. Wild type (WT) and beta2AR knockout (beta2KO) mice underwent analyses of left ven-
tricle function and structure. Electrocardiogram and respiratory-gated magnetic resonance imaging as
well as conductance pressure-volume (PV) catheter studies were performed.
RESULTS. MRI analyses revealed that left ventricle stroke volume (SV) and end diastolic volume
(LVEDV) were significantly greater in WT compared beta2KO mice (p=0.02 and p=0.0005, unpaired
t-tests). PV loop studies demonstrated significantly reduced cardiac contractility (slope of the end sys-
tolic pressure-volume relationship) in beta2KO mice relative to WT animals (p=0.007, unpaired t-test).
CONCLUSION. Our MRI SV data suggested that left ventricle performance of WT mice might be
more robust than that of beta2KO mice. Our PV loop data were consistent with the MRI findings and
demonstrated that differences in the cardiac performance were not simply a result of differences in
preload. Cardiac contractility was impaired in beta2KO mice. Absence of beta2ARs during develop-
ment might cause structural changes that lead to reduced cardiac inotropic performance of beta2KO
mice. We are currently testing this hypothesis using conditional beta2KO mice in which beta2AR
expression is suppressed only in adult animals. We favor the hypothesis that beta2ARs facilitate the
primary role of the beta1ARs in stimulating cardiac contractility. According to this hypothesis, direct
interaction between beta1ARs and beta2ARs (e.g., heterodimer formation) or interaction at the intra-
cellular signaling level might occur. In the absence of these interactions, attenuation of b1AR-mediated
stimulation of inotropic performance would be expected.
Grant acknowledgement. U. S. NIH (NHLBI) 5K08HL75519-2
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EFFECT OF CARDIAC RESYNCHRONIZATION ON PULSE PRESSURE VARIABILITY
IN CHRONIC HEART FAILURE
Keyl C1, Stockinger J2, Laule S1, Staier K1, Schiebeling-Ro¨mer J2, Wiesenack C3
1Department of Anesthesiology, 2Department of Rhythmology, Herz-Zentrum, Bad Krozingen,
3Department of Anesthesiology, University Hospital, Regensburg, Germany
INTRODUCTION. Pulse pressure variation has been established as a dynamic variable of cardiac
preload indicating fluid responsiveness in mechanically ventilated patients. As hemodynamic fluctu-
ations are also influenced by myocardial performance, we used cardiac resynchronization as a model
to evaluate the acute effects of changes in left ventricular mechanical efficiency on blood pressure
fluctuations.
METHODS. Twelve patients (eight male, mean age 69 years) suffering from chronic heart failure
EF = 23 ± 5%) who were scheduled for implantation of a biventricular pacemaker/defibrillator were
studied. After induction of general anesthesia patients were normoventilated at a frequency of 10 -
12/min. Non-invasive beat-to-beat recordings of blood pressure (Task Force Monitor, CNS Systems,
Graz) were performed under steady state conditions during right ventricular and biventricular pacing
and were analyzed by power spectral analysis. The area under the curve was calculated for the fre-
quency band corresponding to the frequency of ventilation. Data were logarithmically transformed to
obtain normal distribution and were compared using the Student’s t-test.
RESULTS. During biventricular pacing systolic blood pressure (SBP) remained unchanged (104 ± 19
mm Hg vs. 101 ± 19 mm Hg) and mean pulse pressure (PP) increased slightly (38 ± 7 mm Hg vs. 34
± 8 mm Hg) compared to right ventricular pacing. Respiratory fluctuation of SBP and PP increased
significantly (SBP: 0.111 ± 1.184 ln mm Hg2 vs. - 0.266 ± 1.105 ln mm Hg2; p<0.01; PP: -0.413 ±
1.158 ln mm Hg2 vs. -1.089 ± 1.616 ln mm Hg2; p<0.01) with a twofold increase in the geometric
mean of pulse pressure variability during cardiac resynchronization. Exemplary power spectra of PP
are presented in the figure.
CONCLUSION. Changes in myocardial performance have a major impact on respiratory hemody-
namic fluctuations in ventilated patients. This influence should be taken into consideration when inter-
preting pulse pressure or systolic pressure variation.
Grant acknowledgement. This study was supported by Guidant, Germany.
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LEVOSIMENDAN DECREASES LENGTH OF HOSPITAL STAY FOR PATIENTS WITH
ACUTELY DECOMPENSATED HEART FAILURE
Teerlink J R1, Massie B M1, Colucci W S2, Young J B3, Packer M4, Fisher L D5, Huang B6,
Sarapohja T7
1Cardiology, SFVAMC - Univ. of California, San Francisco, San Francisco, 2Cardiovascular Medicine,
Boston Univ., Boston, 3, Cleveland Clinic Foundation, Cleveland, 4Center for Biostats and Clinical
Science, Univ. Texas Southwestern Medical Center, Dallas, 5, DBA Biostatistical Consulting,
Kenmore, 6Statistics, Abbott, Abbott Park, United States, 7Biostatistics and Data Management, Orion
Pharma, Espoo, Finland
INTRODUCTION. Patients with heart failure can experience frequent and prolonged hospitalizations.
Levosimendan exhibits a dual mechanism of action that causes vasodilation and enhanced myocardial
contractility without increased myocardial oxygen consumption, resulting in rapid and sustained hemo-
dynamic improvement. When compared to placebo, levosimendan resulted in overall improvement in
clinical status, with more patients improved, and fewer worsened, as measured by the primary endpoint
of REVIVE II (p = 0.015). The effect of levosimendan on the length of the initial hospital stay (LOS)
was prospectively evaluated in patients with acutely decompensated heart failure (ADHF).
METHODS. REVIVE II was a multicenter, randomized, double-blind, placebo-controlled study of
600 patients with ADHF who remained dyspneic after treatment with IV diuretics. Patients received a
24-hour IV infusion of either levosimendan or placebo, in addition to standard therapy.
RESULTS. Patients treated with levosimendan had a mean initial LOS of 7.0 days compared with 8.9
days for placebo-treated patients (p < 0.001). Although the median LOS was 6 days in both treatment
groups, a greater number of patients in the levosimendan group had a shorter LOS, while a greater
number of placebo-treated patients had a longer LOS (p = 0.009). Patients treated with levosimendan
spent fewer average days in intensive or coronary care units (3.9 vs. 4.5 days; p = NS). Although pa-
tients who died during the initial hospitalization or had a missing discharge date were excluded from
this analysis, levosimendan consistently reduced LOS in multiple sensitivity analyses that accounted
for mortality prior to discharge.
CONCLUSION. At discharge from the initial hospitalization, there was a statistically significant re-
duction in LOS for patients treated with levosimendan compared with placebo. In conjunction with
previously reported hemodynamic and clinical benefits, these results add to the favorable clinical pro-
file of levosimendan in patients with ADHF.
REFERENCE(S). Packer M and the REVIVE II Trial Investigators. Circulation 2005;112:3363[abstr]
Grant acknowledgement. Abbott, Abbott Park, IL & Orion Pharma, Espoo, Finland
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LEVOSIMENDAN PROVIDES RAPID AND SUSTAINED IMPROVEMENT IN PATIENT
GLOBAL ASSESSMENT AND DYSPNEA
Teerlink J R1, Packer M2, Colucci W S3, Young J B4, Massie B M1, Fisher L D5, Huang B6,
Sarapohja T7
1Cardiology, SFVAMC - UCSF, San Francisco, 2Center for Biostats and Clinical Science, UT
Southwestern Medical Center, Dallas, 3Cardiovascular Medicine, BU, Boston, 4, Cleveland Clinic
Foundation, Cleveland, 5, DBA Biostatistical Consulting, Kenmore, 6, Abbott, Abbott Park, United
States, 7, Orion Pharma, Espoo, Finland
INTRODUCTION. Levosimendan has a dual mechanism of action that causes vasodilation and en-
hanced myocardial contractility without increasing myocardial oxygen consumption, resulting in im-
proved hemodynamic status. In REVIVE II, levosimendan, compared to placebo, resulted in overall
improvement in clinical status: more patients improved and fewer patients worsened as measured by
the primary endpoint (p = 0.015). Patient-reported ratings of patient global assessment (PGA) and
dyspnea were obtained during and after treatment.
METHODS. REVIVE II was a multicenter, randomized, double-blind, placebo-controlled study of
600 patients with acutely decompensated heart failure (ADHF) who remained dyspneic after treatment
with IV diuretics. Patients received 24-hour IV infusions of levosimendan or placebo, in addition to
standard therapy. PGA and dyspnea ratings, relative to baseline, were recorded at 6, 24, 48, 72, and
120 hours following initiation of treatment.
RESULTS. A greater proportion of patients treated with levosimendan reported moderate to marked
improvement (MMI) in PGA and dyspnea ratings over all time points (p = 0.002; p = 0.018, respec-
tively; generalized linear model using repeated measures). The percent of patients reporting MMI in
PGA was 59.9% for levosimendan and 45.7% for placebo 24 hours after the start of study drug, and
76.6% for levosimendan and 65.6% for placebo at 120 hours (4 days after completion of study drug
infusion). These improvements occurred despite the greater use of rescue therapy in the placebo group.
Results for dyspnea ratings closely paralleled PGA ratings.
CONCLUSION. In REVIVE II, treatment with levosimendan, when compared to placebo, produced
rapid and sustained clinical benefits as assessed by patient-reported ratings, including PGA and dysp-
nea ratings. Improvements in these ratings were maintained for at least 5 days following initiation of
study drug infusion, consistent with the clinical benefit of levosimendan as documented by the primary
endpoint. This is one of the first trials to report sustained clinical improvements resulting from a drug
that has beneficial hemodynamic effects in patients with ADHF.
REFERENCE(S). Packer M and the REVIVE II Trial Investigators. Circulation 2005;112:3363[ab-
str].
Grant acknowledgement. Abbott, Abbott Park, IL and Orion Pharma, Espoo, Finland
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LEVOSIMENDAN PRODUCES A RAPID AND SUSTAINED REDUCTION IN B-TYPE
NATRIURETIC PEPTIDE: SURVIVE
Mebazaa A1, Nieminen M S2, Thakkar R3, Salon J3, Padley R3, Schulz G3
1Anesthesiologie, Hospital Lariboisiere, Paris, France, 2Pulmonary Medicine, Laaketieteen Laitos
Medical School, Helsinki, Finland, 3GPRD, Abbott, Abbott Park, United States
INTRODUCTION. Levosimendan exhibits a dual mechanism of action that causes vasodilation and
enhanced myocardial contractility, without an increase in myocardial oxygen consumption. In RE-
VIVE II, levosimendan resulted in a rapid and sustained reduction in plasma B-type natriuretic peptide
(BNP) concentration. Other studies have associated reductions in BNP with reduced mortality. We
evaluated the effects of levosimendan or dobutamine on plasma BNP concentration and mortality dur-
ing the first 5 days following study drug infusion in patients with acutely decompensated heart failure
(ADHF).
METHODS. SURVIVE was a randomized, multicenter, double-blind, double-dummy study of 1327
hospitalized patients with ADHF who had failed treatment with IV diuretics and/or vasodilators. The
primary endpoint was 180-day all-cause mortality in patients who were treated with IV infusions of
either levosimendan or dobutamine. A secondary endpoint, plasma BNP concentration was determined
at baseline, 24 hours, 3 days, and 5 days using the AxSYM automated immunoassay.
RESULTS. A numerical reduction in all-cause mortality was observed during the first 5 days of the trial
in the levosimendan group compared to the dobutamine group (hazard ratio [HR]=0.72; 95% CI, 0.44–
1.16; p=0.17). There were no significant treatment effects on 180-day all-cause mortality (HR=0.91;
95% CI, 0.74–1.13; p=0.40). Median reductions in plasma BNP concentration were 44% and 28%,
for levosimendan and dobutamine, respectively, at 24 hours (p<0.001); 49% and 7%, respectively, at 3
days (p<0.001); and 47% and 13%, respectively, at 5 days (p<0.001).
CONCLUSION. Levosimendan produced a rapid and sustained reduction in plasma BNP concentra-
tion in patients with ADHF, consistent with the early numerical mortality advantage in the levosimen-
dan group. In contrast, dobutamine resulted in a smaller, transient reduction in plasma BNP concen-
tration. The effects of levosimendan on plasma BNP concentration in SURVIVE were consistent with
those seen in REVIVE II.
REFERENCE(S). Teerlink J R, Massie B M, Colucci W S, et al. J Am Coll Cardiol 2006;47(suppl
A):86A[abstr].
Grant acknowledgement. Abbott, Abbott Park, IL and Orion Pharma, Espoo, Finland
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SERUM TRANSTHYRETIN AS PREDICTOR OF DEAD IN CRITICALLY ILL PATIENTS
Sotillo Diaz J1, Bermejo Lopez E E1, Villanueva Florez J J1, Garcı´a Olivares P P1, Jaspe Codecido A
A1, De Pablo A A1, Gomez Garcia J J M1, Santa -Teresa Zamarro P P1
1Critical Care Unit, Hospital General Universitario Gregorio Maran˜on, Madrid, Spain
INTRODUCTION. Serum transthyretin levels is an ideal marker for monitoring patients who are mal-
nourished or suffer metabolic consecuences of acute stress injury.
The objetive is to establish a correlation between plasmatic thansthyretin levels, admission to ICU and
morbimortality, determining its predictive capacity.
METHODS. Prospective study, include all patients admitted, consecutively, to the ICU of a tertiary
hospital, during a period of 6 month in 2005. Data collection included serum transthyretin levels at ICU
admittance, demografic data, primary diagnoses, severity score systems, complications and discharge
data.
RESULTS. During the time of study, 346 patients were included (62% male). The mean age was 60.5
± 17.8 years, and 75% of patients come from the emergency department. Primary diagnoses at ICU ad-
mission: severe sepsis/septic shock 27.3%, respiratory failure 23.6%, acute neurological events 18.6%,
cardiac failure 10.2%, drug intoxication 5.6%.
Complication during ICU stay: nosocomial pneumonia 13%, ARDS 14%, renal failure 13%, MODS
19.6% and some type of complication 36.7%. ICU mortality was 25.2% and hospital mortality 33.9%.
Patients with lower transthyretin levels (< 13 mg/dl) had a higher incidence of complications (63.5%
vs 15.6%; Relative risk 9.25, IC 95% 5.4 – 15.6), severe infections (21.5% vs 8.1%; RR 3.1, IC 1.5 –
6.1), nosocomial pneumonia (20.1% vs 6.9%; RR 3.4, IC 1.6 – 6.8), ARDS (26.2% vs 3.5%; RR 9.8
IC 4.1 – 24.1), multiple organ dysfunction (40.9% vs 0.6%,; RR 11.9 IC 6.2 – 18.7) and renal failure
(24.8% vs 2.9%; RR 11.1 IC 4.2 – 29.1), higher ICU mortality (49% vs 4.6%, RR 19.8 IC 9.1 – 43.1)
and in-hospital mortality (66.4% vs 5.8%; RR 32.2 IC 15.6 – 66.5). There is a significative statistical
correlation between transthyretin serum levels and APACHE II (r -.473 p .000), APACHE III (r -.489
p .000), SAPS II (r .497 p .000), SOFA (r -.542 p .000), MODS (r .560 p .000) and MOFS (r -.556
p .000). Univariant analysis and logistic regressions shows that serum transthyretin is an independent
predictor of dead (OR 0.681, IC 95% 0.625 – 0.743), this predictive capacity persist whent adjust for
age, gender, severity of illness and primary diagnoses.
CONCLUSION. Serum transthyretin levels at ICU admittance are reliable predictors of morbimortal-
ity in critically ill patients.
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SPLANCHNIC BLOOD FLOW, ENTERAL NUTRITION AND DOPEXAMINE IN ELDERLY
CARDIAC SURGERY PATIENTS
Rapp Kesek D1, Joachimsson P2, Karlsson T2
1Anaesthesiology, Heart Centre, University Hospital, Umea, 2Anaesthesiology, University Hospital,
Uppsala, Sweden
INTRODUCTION. Elderly patients are at risk of organ dysfunction due to underperfusion. Dopex-
amine (Dpx) and enteral nutrition (EN) are used to increase splanchnic blood flow. We compared EN
and Dpx after cardiopulmonary bypass.
METHODS. In 16 patients undergoing coronary artery bypass grafting or aortic valve repair, pul-
monary artery and hepatic venous catheters and nasogastric tube were placed. On first postoperative
day, indocyanine green infusion was started. Patients were randomised to Dpx 1 ug/kg/h (Dpx group)
or enteral nutrition (bolus=100 ml then 50 ml/h;EN group). All received both dopexamine and EN after
180 min. Cardiac index (CI) and splanchnic blood flow (SBF) were measured every 45 min. Blood was
drawn from hepatic vein, pulmonary and radial artery.
RESULTS. The groups did not differ in systemic or splanchnic oxygen consumption. Dpx, but not EN,
increased CI initially. CI was higher in the Dpx group throughout the study, and increased over time
in both groups. When Dpx was added to the EN group, cardiac index (CI) increased. SBF increased
initially after Dpx and then decreased to baseline. There was no difference in CI or SBF when EN
was added to the Dpx group. See table: Steady state 1=after addition of initial substance; Steady state
2=after addition of second substance; SBFI=splanchnic blood flow total/body surface area (TBSA);
VO2I=systemic O2 consumption/TBSA; VO2Is=splanchnic O2 consumption/TBSA. Values: mean+/-
SEM.
TABLE 1.
Intervention Baseline Steady state 1 Steady state 2
CI (L/min/m2) Dpx 3.2+/-0.2 3.6+/-0.1 3.7+/-0.2
CI (L/min/m2) EN 2.9+/-0.1 3.0+/-0.2 3.7+/-0.2
SBFI (mL/min/m2) Dpx 580+/-55 607+/-55 551+/-43
SBFI (mL/min/m2) EN 481+/-42 505+/-48 655+/-66
VO2I (mL/min/m2) Dpx 144+/-9 140+/-8 150+/-7
VO2I (mL/min/m2) EN 126+/-7 134+/-9 131+/-10
VO2Is (mL/min/m2) Dpx 29+/-3 26+/-2 23+/-2
VO2Is (mL/min/m2) EN 23+/-2 26+/-3 26+/-2
CONCLUSION. Dpx and EN did not increase O2 consumption. EN did not increase SBF or CI. Dpx
increased systemic blood flow, but had no clear effect on SBF.
Grant acknowledgement. Swedish Heart-Lung Foundation, Selanders Foundation
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EXOGENOUS GLUTAMINE UTILIZATION IN HEAD TRAUMA PATIENTS
Berg A1, Bellander B1, Wanecek M2, Gamrin L3, Rooyackers O2, Wernerman J2
1Neurosurgery Department, 2Anaesthesiology and Intensive Care, Karolinska University Hospital,
Karolinska Institute, 3Anaestheisology and Intensive Care, Danderyd Hospital, Stockholm, Sweden
INTRODUCTION. ICU patients with Multiple Organ Failure (MOF) benefit from iv glutamine sup-
plementation in terms of mortality and morbidity. Also neurosurgical patients in the ICU may be can-
didates for exogenous glutamine support, but in head trauma patients there are concerns regarding the
close connection between glutamine and glutamate. Elevated intracerebral levels of glutamate are seen
in patients with high ICP and an unfavourable outcome. We have recently reported that cerebral gluta-
mate concentration is not influenced during an intravenous glutamine infusion in head trauma patients.
Here the utilization of exogenous glutamine was studied.
METHODS. Patients (n=15) with severe head trauma (GCS<8) in the ICU were studied. Study proto-
col had a cross over design where patients were randomised to receive glutamine (dose 0.34g/b.w/20h)
before placebo or placebo before glutamine on two consecutive 24 h periods. The decay of plasma
concentration after the end of the glutamine infusion was used to calculate rate of appearance (Ra) for
glutamine. Student’s T-test for paired samples was used.
RESULTS. During glutamine infusion plasma glutamine concentration increased by 40%, (644±212,
v. 461±200 µmol/L; p=0.00001) while glutamate concentration was unaltered. AV-difference across
the brain (a-v- jugular) indicates a glutamine efflux. (-49± 26, v. -27±14 µmol/L; p=0.02), while
glutamate balance was not different from zero. Glutamine flux across the leg was not significant differ-
ent between glutamine infusion and control periods (treatment day -171±124, control day -143±105
nmol/100ml/min; p=0.45). Glutamine Ra was 273±86 µmol/kg/h.
CONCLUSION. Exogenous glutamine was not utilized in the brain or in muscle. In addition the
endogenous production of glutamine was within the normal range. Hypothetically the exogenously
supplied glutamine was mainly utilized in the splancnic area, where more glutamine was used than is
normally produced endogenously.
Grant acknowledgement. Swedish Medical Research Council
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EVALUATION OF SUBCUTANEOUS GLUCOSE MEASUREMENTS IN PATIENTS WITH
SEVERE SEPSIS
Korsatko S1, Mader J1, Ikeoka D1, Plank J1, Bodenlenz M2, Schaupp L2, Mautner A1, Smolle K1,
Pieber T R1, Ellmerer M1
1Department of Internal Medicine, Medical University Graz, 2Department of System Technology and
Health Management, Joanneum Research GmbH, Graz, Austria
INTRODUCTION. Tight glycaemic control improves outcome in critically ill patients but requires
frequent blood glucose monitoring. Subcutaneous adipose tissue (SAT) has been characterised as a
promising site for glucose monitoring in diabetic patients. However, tissue perfusion might be altered
in critically ill patients and therefore it remains unclear whether glucose in SAT can be used as alterna-
tive for blood glucose monitoring. The present study was performed to evaluate the relation of glucose
in SAT compared to arterial blood using a well accepted insulin titration guideline in patients under
severe septic conditions.
METHODS. 10 critically ill patients with severe sepsis were investigated. Arterial blood and SAT
microdialysis samples were taken in hourly intervals for a period of 26h. Glucose concentrations from
SAT were calibrated to arterial blood glucose (Bg) by one point calibration using the first Bg reading
(BgSAT1h), or using the Bg reading after 6 hours (BgSAT6h) to allow stabilisation of the tissue af-
ter insertion of the microdialysis probe. The relation between blood (Bg) and calibrated SAT glucose
readings was clinically evaluated applying a newly established insulin titration error grid analysis.
RESULTS. Glucose readings between arterial blood and SAT were comparable (Bg: 143 [122 to 167]
mg/dl; BgSAT1h: 147 [130 to 177] mg/dl; BgSAT6h: 146 [117 to 181] mg/dl; median [25% and 75%
percentiles]). Relative differences between arterial blood vs. BgSAT1h or BgSAT6h indicated -2 [-193
to 30] % and -4 [-42 to 25] %; median [5% and 95% percentiles] respectively. Clinical evaluation of the
data revealed that out of 220 (BgSAT1h) and 175 (BgSAT6h) paired glucose readings, 86% (BgSAT1h)
and 95% (BgSAT6h) would allow acceptable treatment according to a well established insulin titration
guideline. 14% of the data for BgSAT1h and 5% for BgSAT6h would cause a violation of the insulin
titration guideline.
CONCLUSION. Under conditions of severe sepsis, paired glucose readings indicate a close relation
between arterial blood and SAT. Introduction of a 6-hour stabilisation period for the trauma as caused
by the microdialysis probe results in a substantial improvement of this relation. Overall, the major-
ity of the data suggests SAT as a possible alternative measurement site for glucose to establish tight
glycaemic control in patients who developed severe sepsis.
Grant acknowledgement. Funded by the European Commission as part of CLINICIP FP6 IST
506965.
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IIT REDUCES CRITICAL ILLNESS NEUROMUSCULAR COMPLICATIONS AND PRO-
LONGED VENTILATION IN A MEDICAL ICU
Hermans G1, Wilmer A1, Meersseman W1, Bruyninckx F1, Milants I1, Wouters P1, Bobbaers H1,
Van den Berghe G1
1University Hospitals, KU Leuven, Leuven, Belgium
INTRODUCTION. Critical illness polyneuro-and/or myopathy (CIPNMP) is a major problem in crit-
ically ill patients causing limb weakness, prolonged mechanical ventilation (MV), extended hospital
stay and increased mortality. Recently, the incidence of CIPNMP in a surgical ICU was reduced in
patients receiving intensive insulin therapy (IIT). We investigated whether IIT could similarly reduce
CIPNMP and prolonged MV in a high-risk population in a medical ICU.
METHODS. This study is a subanalysis of a large RCT (1200 patients) comparing outcome in a med-
ical ICU using IIT or conventional IT (CIT). We analyzed CIPNMP and prolonged MV in a subgroup
with an ICU stay of at least 7 days with weekly EMGs of all limbs. Diagnosis of CIPNMP was based
on abundant spontaneous activity (sharp waves/fibrillation potentials), only if present in multiple distal
and proximal muscles in all extremities. Baseline and outcome variables were compared using Stu-
dent’s t, Chi-square or Mann-Whitney test when appropriate. The effect of treatment allocation was
assessed using multivariate logistic regression, correcting for baseline and ICU risk factors. The latter
were also evaluated using cumulative hazard estimates and proportional hazards regression analysis,
censoring for early deaths.
RESULTS. 420 patients were evaluated. CIT and IIT groups were comparable on admission. In-
hospital mortality in the IIT group was 46.1% vs. 56.1% in the CIT group (p=0.04). CIPNMP was
more frequent in the CIT group (50.5% vs. 38.9%) (p = 0.02). Prolonged positive EMG findings (at
least 2 positive EMGs) were also reduced in the IIT group (17.3%, vs 27.4%, p=0.01). Multivariate
logistic regression demonstrated IIT as an independent protective factor for CIPNMP (p=0.03) after
correction for baseline severity of illness and known risk factors. Mean daily glucose levels and insulin
dose could not independently explain the benefit of the IIT group. After correction for these however,
corticosteroids had a protective effect on the occurrence of CIPNMP (p= 0.01). IIT also reduced pro-
longed MV from 46.7% (CIT group) to 34.6% (IIT group) (p= 0.01). IIT remained an independent
protective factor for prolonged MV (p= 0.03) in a multivariate logistic regression model correcting for
preadmission risk, diagnostic categories and organ failure.
CONCLUSION. IIT reduces CIPNMP and thereby prolonged MV in a medical ICU population with
a high incidence of other known risk factors for this disease.
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PATHOPHYSIOLOGY OF HYPERLACTATEMIA DETERMINES PROGNOSTIC CHARAC-
TERISTICS OF LACTATE
Jansen T C1, Mulder P G2, Bakker J1
1Intensive Care, 2Epidemiology and biostatistics, Erasmus MC University Medical Center, Rotterdam,
Netherlands
INTRODUCTION. Hyperlactatemia has been associated with high mortality. However, pathophysi-
ology of hyperlactatemia varies according to the underlying disease and this has not been related to
prognosis. The aim of this study was to analyze the prognostic characteristics of lactate in different
types of critical illness.
METHODS. In this prospective observational study we evaluated ICU patients of 2 university affili-
ated hospitals from May 2000 to April 2002. Lactate levels were collected at admission (T=0), T=12
and T=24 hrs and in- hospital mortality was recorded. We enrolled 421 patients of which 27 re- admis-
sions were excluded. Patients were classified as SEPSIS (sepsis, severe sepsis or septic shock, n= 115),
LOW FLOW (hemorrhagic or cardiogenic shock, n= 108) or OTHERS (n= 171) by admission diagno-
sis of the Dutch National Intensive Care Evaluation (NICE) registry. After withdrawal of patients with
incomplete lactate measurements 92 SEPSIS patients remained for comparison with 80 LOW FLOW
patients.
RESULTS. Analysis was performed in 172 patients with mean age 67±14 yrs. Mean APACHE II was
18.6±6.8 and in-hospital mortality was 28.5%. In the SEPSIS group mean lactate levels (mmol/l) of
survivors and non- survivors at T=0 were 2.9±0.2 vs 2.9±0.4 (p=0.934), at T=12: 2.4±0.3 vs 3.4±0.6
(p=0.056) and at T=24: 1.9±0.1 vs 3.3±0.8 (p=0.008). In the LOW FLOW group mean lactate lev-
els of survivors and non- survivors at T=0 were 3.2±0.3 vs 6.1±1.0 (p< 0.001), at T=12: 1.9±0.3 vs
3.1±0.4 (p< 0.001) and at T=24: 1.7±0.1 vs 2.3±0.4 (p=0.041). The effects of the lactate evolutions
during the first 24 hours on mortality were significantly different between the two groups (p= 0.047).
In the SEPSIS group each 10% decrease in the 12 to 0 hrs lactate ratio resulted in a 12.5% lower mor-
tality rate (95%CI: 4.4%- 19.9%; p= 0.003). For 24 to 12 hrs this was 15.8% (95%CI: 5.4%- 25.2%;
p= 0.004). In the LOW FLOW group no significant effects of lactate changes during the first 24 hours
were seen (p= 0.26 and 0.78 for 12 to 0 hrs and 24 to 12 hrs lactate ratio).
CONCLUSION. In septic patients the course of lactate levels over time seems to be a major determi-
nant of outcome. In contrast, in patients with a low- flow state (hemorrhagic or cardiogenic shock) a
strong reduction of lactate within 24 hours does not rule out a detrimental outcome. Here, the initial
lactate level, rather than the ability to decrease lactate over time, predicts outcome.
0405
DAILY CALORIC REQUIREMENTS AND RISK OF INAPPROPRIATE FEEDING IN CRIT-
ICALLY ILL CANCER PATIENTS
Pirat A1, Finch C2, Nates J L2
1Anesthesiology, Baskent University Faculty of Medicine, Ankara, Turkey, 2Critical Care, University
of Texas, MD Anderson Cancer Center, Houston, United States
INTRODUCTION. Accurate determination of caloric requirements, one of the first and essential com-
ponents of nutritional support in intensive care unit (ICU) patients, can be particularly challenging in
critically ill cancer patients. This study was designed to determine the daily caloric requirements and
the incidence of inappropriate feeding in critically ill cancer patients in our ICU.
METHODS. After obtaining Institutional approval, all adult patients who were admitted to the ICU
between March 2004 and July 2005 and had an indirect calorimetry (IC) measurement were included
in this study. Cases with missing or incomplete data were excluded. Specially trained critical care
respiratory therapists performed all IC measurements according to the policies and guidelines in our
ICU. A dietitian performed a complete nutritional assessment for all ICU patients within 72 hours of
admission and calculated the resting energy expenditure (REE) based on a kcal per kilogram equation.
IC was performed in all patients to measure REE (MREE). Underfeeding, appropriate feeding, and
overfeeding were described as calculated REE < 90% of MREE, calculated REE >90% and <110% of
MREE, and calculated REE >110% of MREE, respectively.
RESULTS. Forty two patients (13 males and 29 females) with a mean age of 59.4 ± 16.2 years were
studied. Patients’ mean body weight and body mass index were 86.3 ± 30.1 kg and 29.6 ± 9.6 kg/m2,
respectively. Mean APACHE II score was 19.1 ± 1.2 for this group. Respective estimated REE and
MREE were 1867 ± 337 kcal (22.5 ± 7.8 kcal/kg) and 1620 ± 453 kcal (19.9 ± 5.5 kcal/kg). A
significant correlation was detected between the MREE and estimated REE (p=0.018 and r=0.417),
however the mean values for these two parameters were significantly different (p=0.03). Ten patients
were being underfed (24%), 9 patients were in the appropriate feeding group (21%), and 23 patients
received overfeeding (%55).
CONCLUSION. This study showed that our group of mechanically ventilated critically ill cancer pa-
tients had a lower daily caloric requirement than the generally used 25 kcal/kg/day. Our results also
indicate that estimation of caloric requirements with a kcal per kilogram equation was associated with
a high incidence of both over- and underfeeding in this subgroup of ICU patients. IC remains the best
method of determining patients’ energy needs in the ICU.
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PHYSICAL RESTRAINT USE IN EUROPEAN ICUS
Benbenishty J S1, Adam S2
1Intensive Care, Hadassah Medical Organization, Jerusalem, Israel, 2Critical Care, UCLH, London,
United Kingdom
INTRODUCTION. Patients in intensive care are monitored and treated using a range of invasive de-
vices and equipment. In order to support ongoing acceptance of these measures, the patient must either
be cooperative and competent, sedated, or physically unable to disturb the devices. In order to facili-
tate this, many patients are either chemically sedated or physically restrained to allow effective patient
management to occur. Anecdotally, the practice of using physical restraints in intensive care varies
widely across Europe. Little data is available on the extent and criteria for its use. Most published data
to date is based on practices in the United States. In a study of 17 ICUs in the US, Minnick et al. [1]
found that 24% of patients were restrained, although practice did vary across different types of ICU
The purpose of the present study was to gather exploratory data on the incidence of and the reasons for
physical restraints in adult ICUs in Europe.
METHODS. A prospective descriptive study of incidence of physical and chemical restraint use in-
volving ICUs across Europe was carried out. Recruitment of ICUs occurred through ESICM mem-
bership. ICUs taking part collected data on all adult (>18 yrs) ICU patients hospitalized on 2 data
collection days (One week day and one weekend day). Data collectors were asked to collect the fol-
lowing data. Baseline - Country, Number of beds, nurse:patient ratio. restraint policy Restraint data-
number of patients restrained, reason for restraint, motivation for restraints, alternative measures used
in addition to physical restraints, effectiveness of restraint, physical effect on the patient, length of time
patient is restrained, type of sedation used.
RESULTS. 35 units contributed data from 11 countries in Europe. Mean size of ICU was 14 beds
(range 4-24) with a mean 63 admissions /month (range 15-143). 750 patient episodes were recorded.
27% of these patients were physically restrained and 35% of patients received sedation. Nurse: patient
ratios ranged from 1:1 to 1:4. There did not seem to be a relationship between restraint use and this
ratio. However, there was an association between use of sedation and use of physical restraint. In most
countries, the more patients were physically restrained, the less were sedated. There is an negative
association between number of patients restrained and presence of a physical restraint policy.
CONCLUSION. Levels of physical restraint use vary across Europe but its use would appear to be
cultural rather than as a result of reduced levels of nurse staffing or a deliberate decision to avoid
sedation.
REFERENCE(S). 1) Minnick A. F et al Prevalence and patterns of physical restraint use in the acute
care setting Journal Nursing Administration 1998; 28:19-24.
Grant acknowledgement. This study was endorsed by ECCRN/ESICM.
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STRESS FACTORS IN NURSING STAFF IN AN INTENSIVE CARE UNIT
Abizanda R1, Ballester R2, Bernat A3, Edo M4, Iba´n˜ez M5, Belenguer A3, Mas S3, Heras A3
1ICU Department, Hospital Universitario Asociado General de Castell, 2Basic, Clinic and Psichobiol-
ogy Dpt, 3ICU Deparment, 4Basic, Clinic and Psychobiology Dpt, 5Basic, Clinic and Psychobiology
Dept, Universitat Jaume I, Castello, Spain
INTRODUCTION. Psychological stress is frequently argued as a burning-out factor in nursing staff in
ICUs. Our aim has been to identify the main job factors able to cause such stress in a multidisciplinary
ICU nursing staff.
METHODS. The study was ruled in a multidisciplinary ICU during 2005. Sample size was 56 nurses
and psychological investigation instruments were: the Sanitary Staff Stressing Factors Scale, created
by our group. It is a Likert like scale composed by 40 items through whose answers (ranked in 5 levels
from “not at all - 1” to “very much - 5”) the individual gives information about factors related with
his/her job and causing distress. Staff participation was voluntary, anonymous and confidential and it
was performed on a single fellow basis at each time.
RESULTS. Thirty five (35) percent of nurses express “some” distress related to their job, and they con-
sider their position as “very stressing” in 21% and “very much stressing” in 7%. The 10 more stressing
factors are: too much workload (3.21 +/- 0.84); lack of human manpower (2.74 +/- 1.06); daily work
time pressure (2.48 +/- 1.14); under professional consideration (2.46 +/- 1.14); lack of ruled resting
periods during job (2.46 +/- 1.05); consequences of too much rapid decisions (2.28 +/- 0.99); ele-
vated requirements (2.26 +/- 1.13); uncertainty situations with lacking of information (2.13 +/- 1.09);
emotional overload (2.07 +/- 1.21) and too much responsibility (2.05 +/- 1.23)
CONCLUSION. ICU nursing staff is under a high level of stress associated to their job position.
Main factors causing it are too much workload, professional underestimation, and too much responsi-
bility. It seem of the greatest importance to offer to this staff some kind of programs for establishing
psychological and organizational strategies to help them to cope with their job.
Grant acknowledgement. Investigation funded by the Conselleria de Sanitat del Govern Valencia.
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A MULTIDISCIPLINARY APPROACH TO THE IMPLEMENTATION OF CPAP HOOD
THERAPY
Fazakerley A1, Harper J2, Arthan L2, Francis K2, French J2, McCrossan L2, Vincent L2
1Critical Care Outreach Team, Royal Liverpool and Broadgreen University Hospital Trust, Livepool,
United Kingdom, 2Critical Care Outreach Team, Royal Liverpool and Broadgreen University Hospital
Trust, Livepool
INTRODUCTION. Continuous positive airway pressure (CPAP) is frequently used in critical care
to improve oxygenation. However, some patients cannot tolerate CPAP therapy via a mask because
of physical discomfort or anxiety and we sought an alternative method. The CPAP hood has proven
efficacy and is well tolerated with minimal adverse effects (1,2).
METHODS. Castar CPAP Hoods were procured from Vital Signs Ltd. Clinical guidelines were drawn
up by the Critical Care Outreach team. Patient suitability was assessed by the Outreach nurses and
prescribed by critical care doctors. Treatment was initiated with CPAP mask but if poorly tolerated,
a CPAP hood was used. Some patients’ therapy was initiated with the hood, if for example they had
previous facial surgery or claustrophobia. Extensive training of nursing, medical staff and physiother-
apists was undertaken by the outreach nurse educator in areas of the hospital currently able to care
for patients requiring facial CPAP. Training packs including guidelines, photographs and nursing care
protocols were provided to each area.
RESULTS. The CPAP hood was used on 45 patients in 12 months. Data collected on the first 16 pa-
tients showed the average length of time the hood was worn, was 25.6 hours, with 7/16 patients (44%)
wearing the hood for long periods, and 9/16 (56%) wearing it for intermittent treatments of less than 3
hours at a time. Only 1 patient did not tolerate the hood at all and it was removed after 35 minutes. In
3/16 patients (19%) the hood was used as a weaning treatment after extubation. 6/16 patients (37.5%)
progressed to intubation and ventilation despite using the hood, though one of these patients was in-
tubated for transfer to CT Scan. 10/16 patients (62.5%) never required intubation and ventilation after
having hood therapy. All 16 (100%) patients showed improvement in oxygenation.
Work of breathing was reduced and overall patient comfort was improved. Patient comments were
generally positive. Nursing staff found caring patients with hood therapy easier than a CPAP mask.
CONCLUSION. Though it is recognized a formal trial to compare tolerance, length of treatment,
and progression to ventilation with the two methods of CPAP delivery is necessary, our evaluation has
shown the CPAP hood to be an easy, efficient, well tolerated and safe alternative to CPAP mask therapy.
REFERENCE(S). 1. Antonelli M et al; Critical Care Medicine 2003:30:602-8
2. Tonnelier J M et al; Intensive Care Medicine 2003;29:2077-80.
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EVALUATION OF NURSES’ PERFORMANCE IN ACQUIRING STROKE VOLUME USING
ESOPHAGEAL DOPPLER
Lortat-Jacob B1, Mateo J1, Ke´re´ver S1, Payen D1, Cholley B1
1Anesthesiology and Intensive Care Medicine, AP-HP, Lariboisie`re Hospital, Paris, France
INTRODUCTION. Esophageal Doppler (ED) is a minimally invasive monitor, that estimates stroke
volume (SV) from descending aortic flow velocity. This technique is considered easy to learn, how-
ever, the reliability of SV measurement by ICU nurses has never been evaluated in comparison to
measurements obtained by “expert” physicians.
METHODS. After IRB approval, ICU nurses received a 1-hour theoretical training to learn how to
place ED probe in order to measure flow velocity from the descending aorta. They were asked to ob-
tain the best possible flow velocity signal in stable, sedated, mechanically ventilated patients monitored
by ED (CardioQ, Deltex). The numeric values for SV and parameters derived from the velocity enve-
lope remained hidden, and the signal was considered optimal when spectral brightness and peak flow
velocity were maximum. Gain was adjusted to optimize signal/noise ratio. The monitor was set to av-
erage SV values over 5 cardiac cycles to minimize respiratory variability. The operators (nurses and
experts) were asked to freeze the scrolling when they thought they had obtained the best signal, and an
independent observer recorded the SV values. After SV acquisition, the probe was retrieved by a few
centimeters to loose the signal and the operator was asked to replace it two more times. Experts com-
pleted their SV acquisitions immediately before or after nurses. SV values obtained by nurses (SVnurs)
and experts (SVexp) were calculated as the average of the 3 consecutive measurements. Correlation and
agreement between SVnurs and SVexp have been studied, as well as intra-observer reproducibility for
each category. A Mann-Whitney test was used to check if bias was statistically different from 0.
RESULTS. 36 nurses and 3 experts have made 125 triplets of SV measures in 35 patients. Mean SV
measured by the experts was 68 +/- 20 mL, and by the nurses was 66 +/- 21 mL. Intra-observer repro-
ducibility was 10%, for both, nurses and experts. The correlation between SVnurs and SVexp was very
tight (r2=0.88), and the agreement was characterized by a systematic bias of + 2 mL (SVexp > SVnurs;
p<10-4) and limits of agreement of +/- 14 mL.
CONCLUSION. After a minimal training, ICU nurses acquired an intra-observer reproducibility sim-
ilar to that of expert operators for SV measurement. Correlation and agreement for SV values obtained
by each category were satisfactory. However, experts did achieve greater SV values consistently, indi-
cating a better probe placement.
0410
EVALUATION OF ICU ADMISSIONS OF PATIENTS WITH AN IN-HOSPITAL CARDIAC
ARREST BEFORE AND AFTER INTRODUCTION OF “DO-NOT-RESUSCITATE” ORDER
Bakker K M M1, Spanjersberg R1, Ligtenberg J J M1, Meertens J H J1, Tulleken J E1, Zijlstra J G1
1Intensive and Respiratory Care Unit, University Medical Centre Groningen, Groningen, Netherlands
INTRODUCTION. When an acute life threatening event occurs within the medical department, a car-
diopulmonary resuscitation team of the medical Intensive Care Unit is immediately alerted. This CPR
team is specifically designated resuscitation team, available 24 hours a day. In 2001 an DNR protocol
was introduced at the medical department in our hospital for all admitted patients. The physician on
the ward decides the DNR status in consultation with the patient or relatives on admission with ad-
justment of the decision whenever necessary. The DNR code is recorded in the patient’s medical file.
The aim of this study is to determined whether the introduction of the DNR protocol, in the medical
department, influences the total number of outreaches, the ICU-admissions and the overall survival the
first 24 hours after CPR.
METHODS. Between 1997 and 2005 all events where the CPR-team was involved were recorded in a
logbook and described according to characteristics and outcome. False alarms were omitted. We com-
pared the results before (1997-2001) and after (2001-2005) the introduction of the DNR protocol. (the
survival was compared from 1998-2000 and 2001-2003 because survival data was missing in the year
1997)
RESULTS. In the period 1997 – 2000 the CPR team was alerted 167 times. In comparison, in the pe-
riod 2001-2004 the CPR team was alerted 100 times. This is a significant decline (P = 0.0156). When
comparing the 2001-2004 with the 1997-2000 period one can also see a significant decline in the num-
ber of ICU admissions after CPR; 71 versus 41 (P < 0.01). In the period before the introduction of the
DNR protocol the percentage of patients who were alive after 24 hours was 14% for cardiac arrest pa-
tients, 69% for respiratory arrest and 84% for other serious events. In the period after the introduction
the percentage of patients who were alive after 24 hours was 14% for cardiac arrest patients, 67% for
respiratory arrest and 93% for other serious events.
CONCLUSION. The introduction of a DNR protocol has led to a significant reduction in emergency
calls and also a significant reduction in ICU admissions after CPR. There is no shift in type of event.
The 24 hour survival percentage for cardiac arrest, respiratory arrest and other serious events is roughly
the same before and after the introduction of a DNR protocol.
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EFFECTIVENESS OF EARLY EXERCISE IN CRITICALLY ILL PATIENTS: PRELIMI-
NARY RESULTS
Burtin C1, Clerckx B2, Robbeets C2, Galle S3, Pillen R2, Leclercq H2, Caluwe´ K2, Lommers B2,
Wilmer A3, Troosters T1, Ferdinande P3, Gosselink R A2
1Faculty of Kinesiology and Rehabilitation Sciences, 2Respiratory Rehabilitation, 3Intensive Care
Medicine, University Hospitals KU Leuven, Leuven, Belgium
INTRODUCTION. Critically ill patients often have a prolonged ICU and hospital stay, associated
with deconditioning and muscle weakness. This prospective trial examined whether an early daily cy-
cling session program while still bed-bound could reduce the level of deconditioning and thus reduce
hospital stay.
METHODS. Stable patients, ventilatory supported for at least 5 days, were randomized into an ex-
perimental and a control group. Both groups received identical medical treatment and daily sessions
of chest physiotherapy, standardized mobilizations and functional rehabilitation. In addition, the exer-
cise group was treated with active or passive cycling sessions for 20 minutes per day using a bedside
ergometer. Functional status was assessed using item 1 of the Berg Balance Scale (BBS), Functional
Ambulation Categories (FAC) and the Physical Functioning item of the SF36 Health Questionnaire.
Six-minute walking distance (6MWD) at hospital discharge and length of hospital stay (LOS) were
registered.
RESULTS. Results are reported in Table 1. We included 37 patients (mean age 55±18; 68% male).
There was no difference in APACHE II score (13.2±5.5) between groups. The experimental group had
a statistically significant better functional outcome at hospital discharge as measured with PF SF36. At










BBS (score) 2.3±1.9 1.6±1.6 4.1±1.2 4.8±0.5
FAC (score) 1.5±1.8 0.8±1.6 3.4±1.3 4.0±0.9
PF SF36 (score) 15.9±4.3 19.9±4.2*
LOS (days) 33.2±13.1 28.7±10.4
6 MWD (% pred) 36±19 43±15
* p<0.05 vs control group; results are means +/-SD
CONCLUSION. Interim analysis indicates that early exercise in critically ill patients improves sub-
jective functional status at hospital discharge, but we could not demonstrate a beneficial effect at ICU
discharge.
Grant acknowledgement. RECK MOTOmed, Germany; Enraf Nonius, Belgium
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PHYSICAL TRAINING IMPROVES EXERCISE TOLERANCE AND QUALITY OF LIFE
(QOL) AFTER CRITICAL ILLNESS.
Murphy S1, Creaney A1, Lavery G G2
1Physiotherapy Dept and Regional Intensive Care Unit, Royal Hospitals, 2Faculty of Health and Life
Science, University of Ulster, Belfast, United Kingdom
INTRODUCTION. Pumonary rehabilitation programmes have been shown to benefit chronic obstruc-
tive pulmonary disease (COPD) patients (1). We hypothesized that the physical training component of
such a programme would improve exercise tolerance and QoL in former intensive care unit (ICU)
patients without COPD.
METHODS. Former (non-COPD) ICU patients were screened for study inclusion, using previously
published criteria (2) and, after hospital discharge, commenced a 6 week exercise programme. This
involved 2 hospital-based treatment sessions in the physiotherapy dept. and one home exercise ses-
sion per week. Exercise tolerance and QoL were measured using the incremental shuttle walking test
(ISWT), a treadmill exercise test (TRDEX), pulmonary function tests (PFTs) and the Functional Lim-
itations Profile Questionaire (FLP). All assessments were performed before and after the 6 week pro-
gramme.
RESULTS. Five consecutive subjects fulfilling the entry criteria entered the pilot study. Mean (SD) val-
ues were; age 55.2 (12.9) yrs, length of stay in ICU 37.8 (52.7) days, duration of mechanical ventilation
36.2 (52.5) days, admission APACHE II score 18.2 (11.1). Each subject completed the programme and
had improved PFTs, ISWT, TRDEX and FLP scores. Group data (Table 1) showed significant improve-














Baseline 206 (182) 0.60 (0.57) 1.54 (0.20) 276 (98) 50.2 (18.0) 39.8 (8.0)
6 weeks 354 (155) 1.27 (0.82) 1.99 (0.36) 388 (157) 11.8 (4.9) 12.0 (9.8)
P-value 0.005 0.005 0.010 0.042 0.015 0.004
Mean (SD) values / 2-tailed pairedT-test
CONCLUSION. A six week course of physical training was associated with improved exercise toler-
ance, pulmonary function and QoL in a small group of former (non-COPD) ICU patients. We intend
to conduct a larger controlled study.
REFERENCE(S). 1. Kaplan R A L, Limberg T M, Prewitt T M (1995). Ann. Intern. Med. 122, 823-
832.
2. Jones C, Skirrow P, Griffiths R et al (2003). Crit. Care Med.31, 2456-2461.
